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Introduction 
Instructor:  Edward N. Harris 
Department:  Biochemistry 
Course:  Biochemistry 435, Advanced Topics in Biochemistry 
University:  University of Nebraska – Lincoln 
Contact Info:  1901 Vine St., Beadle N133, Lincoln NE  68588.  Ph # 402-472-7468; 
email:  eharris5@unl.edu 
Objectives of Peer Review Course Portfolio 
The objectives of this course portfolio are to assess how this course is meeting its goals 
and objectives within the ACE 10 framework.  ACE (Achievement Centered Education) is a 
designation in which students are required to produce a scholarly product within their major 
studies during their undergraduate years.  In writing up this document for peer review, I attempt 
to analyze how my course is meeting the objectives for ACE 10 criteria and if the students are 
really getting trained in critical thinking as they build their scholarly product based on the 
scientific literature.  Since teaching this course several times over the past 3 years, I also 
wanted to understand how my modifications have refined the course into a better tool for 
student learning.  Therefore, my objectives for the portfolio are, 1) how are my teaching 
refinements and activities improving the course, 2) are my assessment methods for evaluating 
student learning during the semester sufficient, and 3) is my course meeting all of the 
requirements for ACE 10? 
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Description of the BIOC 435 Course (Appendix I) 
The objectives or goals for this course (as part of the ACE 10 criteria) are as follows: 
• To integrate overall biochemistry knowledge and understanding with emphasis is sugar
biochemistry.  I chose sugar biochemistry because this area of research and
understanding in both the biomedical (an area in which many students are trying to apply
for) and biotechnology fields is increasing in both importance in human biology and
medicine in addition to how synthetic biological can be applied to human-based
therapies.  Sugar biochemistry is not taught at the University of Nebraska in any detail
and is slightly touched upon in the general biochemistry course (BIOC 431).
• To learn to read and critique the primary literature and experimental methods in
biochemistry.  Some of the most difficult literature to read in the English language is the
scientific research paper due to the techniques and new information that is presented.  A
research paper is regarded as the “primary” literature in which new knowledge is found
in a laboratory setting or in field work and the results and interpretation of those results
are written up by those who discovered them.  Those who read the primary literature in
the biological sciences are required to have sufficient understanding of the
methodologies and concepts in both biochemistry and life sciences.  Although the
authors of a paper may insist that their methodology and interpretation of results are the
most correct, this is not always the case and the students are encouraged to think of
alternative methods that could have been used as well as how the data may be re-
interpreted or confirmatory.
• To become acquainted with sophisticated topics in biochemistry and be able to
contribute to group discussions about the literature related to these topics.  This course
teaches the students new knowledge and concepts concerning the impact of sugar
modifications in protein biochemistry as well as sugars in metabolism.  In the classroom
setting, I (the instructor) encourage the students to debate issues regarding the uses of
sugars in human consumption and in the biotechnology areas.  The students also need
to work in groups to discuss this material in a class presentation.
• To apply your biochemical knowledge to new areas within the life sciences.  As new
knowledge is attained about sugar biochemistry specifically and exposure to biological
sciences in general via their readings in the primary literature, it is hoped that the
students will see how application of methodologies and concepts are applicable in other
areas such as medicine, crop sciences, genetics, etc.
• To organize and present biochemical research data in oral and written formats.  Both the
oral and written presentations make up two of the three major assessments areas in this
course and will be discussed in greater detail later.  The objective of both formats is to
determine if the students understand what they read in the literature.  As part of the ACE
10 program, this objective serves two purposes:  1) If the student goes on to graduate
school, (s)he will be much better prepared as an incoming graduate student to
understand the biological sciences, and 2) these exercises enhance the overall
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knowledge and skill set of a student that is valuable in the work force regardless of what 
career the student chooses. 
• To increase student engagement in the course, both in the lecture part of the class as
well as student involvement on projects done outside of class lecture times.  The
addition of JITT methodology will, hopefully, enhance student participation for the lecture
series in the course.  I am still fine-tuning what will aid the students to fully participate in
joint student projects and other assignments in the course.
Demographics/Enrollment:  This course is composed primarily of ~25 college seniors and it is 
typically their last biochemistry course at UNL.  Some students take this course in parallel with 
BIOC 432 and 433.  BIOC 431 is a pre-requisite for the course and covers the fundamentals of 
carbohydrate, lipid, and protein metabolism. 
Why This Course Was Chosen 
This course was chosen by myself for the following reasons:  1) it is the only course I 
teach at UNL and I would like it to be one of the best classes these students take in their major 
courses, 2) since it is a capstone course, it is a representation of the culmination of experience 
of the students in the biochemistry major, 3) it is capped at 25 students which makes the course 
small enough to really engage the students both collectively and individually, and 4) there are 
several outcomes that need to be assessed in this type of course such as a) writing, b) oral 
presentation, c) critical thinking, and d) ethics that qualify it as an ACE 10 course.   The 
assessment of student learning when these students come from many backgrounds (both 
domestic and foreign) is a difficult task in that the evaluation is a process and not delivered on a 
one-time basis.  All of the prerequisite courses for this class are the traditional courses taught at 
all comparable universities in that the students sit in a large lecture hall, take notes on the 
lecture, and then study those notes for the exam.  They also participate in some laboratory-type 
courses to get some hands on experience with basic methods such as separation of nucleic 
acids and proteins, DNA purification/manipulation, and some enzymology experience.  BIOC 
435 is the first course present to date that forces them to read and provide commentary on the 
primary literature.  There are several ways to teach this material and it is not a “one-size fits all” 
approach due to the range of student aptitudes.  I am still experimenting with several methods 
that other professors from both UNL and at other universities have used that seem to work in 
optimizing student learning for understanding the primary literature.  Some of these methods 
include writing abstracts from published papers that have been annotated and using Just-in-
Time Teaching (JiTT) methodology in some of the lecture portions of the class.  The intended 
use of this portfolio is to serve as a foundation for optimizing the BIO 435 course that I teach 
and as a template/resource for the other 3 faculty that teach this course.  It is also to be used for 
the teaching section of my tenure P & T file and as part of the 2014 ACE 10 assessment project 
that my department is participating in as a UNL-wide effort for ACE 10 accreditation.   
Course Activities 
The Bioc435 course is designed as a capstone ACE 10 (Achievement centered education) 
course and must follow several criteria including 1) critical thinking, 2) technical writing, 3) oral 
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communication, and 4) ethics.  These criteria are assessed through several different types of 
activities although their general topic area is chosen by the instructor.  In my course, the topic 
area is “Glycobiology” 
Lecture:  Throughout the semester, the instructor gives 12 lectures starting with basic sugar 
chemistry to complex modified sugar polymers and the enzymes that synthesize them.  It is 
fundamental that the instructor gives these lectures as a foundation for what they will be 
exposed to in the research papers that are presented by the students and their own topical 
areas for writing the review paper.  The lectures tend to be areas in biochemistry that the 
students have not been exposed to in previous courses in the major, thus, the information is 
new and somewhat complex for the students to grasp.  To increase their engagement with the 
material and their overall comprehension, the instructor uses several Just-In-Time Teaching 
(JiTT) methods during or before lectures to stimulate the student’s curiosity.  These include A) 
questions that will be answered by the students out of class and turned in by email/Blackboard 
submission by a pre-determined time and B) student responses in class via index cards.  The 
class is capped at 25 students and is small enough to use the index card method.  Both 
question types will be evaluated either in-class (B) or right before the following lecture (A).  
Lectures are mainly delivered by PowerPoint with some chalkboard work to emphasize certain 
important points.  Assessment of these activities will be based on student participation as there 
is no “right” or “wrong” answer for these questions.   
Critical thinking:  There are several activities in this course that will require students to critically 
think about the science they are reading and evaluating.  Their first activity is to dissect a 
research article.  This will be done in pairs and in an individual basis.  When done in pairs, both 
students will need to take an article selected by the instructor and break it down to its individual 
components.  They will need to explain what the questions is that the paper is asking and how 
the authors attempt to answer that question.  This will require the students to explain each figure 
of the paper and how and why the figure is important and what part of the question it answers.  
These group papers are based on the lecture content and the presentation of data should last 
the entire class period.  For example, if lecture #3 is on “Advanced-glycation end-products” then 
the paper may be about the metabolism of a specific sugar modification that occurs in vivo.   For 
the second activity, students (working on their own) will be given a pre-selected paper without 
the title, authors, and abstract (redacted form) and be required to write the abstract as if they 
were the author of that paper.  This will require the students to understand the experiments and 
how they (the figures and experiments) are related to each other to formulate the answer to the 
original question posed in the introduction of the paper.  Typically, this paper is not related to 
any lecture material in this course and is typically based on material that the students should 
have already been exposed.  Written abstracts are graded on spelling, grammar, and content.  
The third activity is for students to read through many papers that are on the chosen topic area 
in which they will need to write a review paper.  Typically, a review paper contains more than 
100 referenced papers, though I have found that many students will have around 50 referenced 
papers.  Some students have fewer referenced papers due to the infancy of the field (e.g. C-
mannosylation) or may have many papers as a particular subject may affect many metabolic 
syndromes (e.g. O-GlcNAcylation).   
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Technical writing:  This biochemistry class is the most writing intensive class in this major and 
may be the most writing intensive science course these students take during their college 
experience.   Both abstract writing and the review paper are written on an individual basis and 
will be graded for content, spelling and grammar.  The abstract writing is submitted and graded 
without any revision allowed.  The students will write 3 abstracts from 3 redacted papers over 
the course of the semester.  The review paper, which is meant to be the scholarly output of this 
course, is evaluated in sections over the course of the semester.  The students will turn in an 
outline, followed by the introduction, followed by the first chapter, followed by the entire rough 
draft by specific dates chosen by the instructor.  This is to help them 1) to avoid procrastination 
of starting to write a paper the day before it is due, 2) allows them to get feedback on the 
content and writing style early on so as to revise what has been written for subsequent 
submissions.  It is understood that the students may not be expert writers by the end of the 
semester, but the goal is to put them through this exercise so that their writing may be improved 
by the end of the semester and so they will gain an appreciation of how to write a thoroughly 
researched review article.  The review paper is assessed and graded on the rubric provided in 
the syllabus which is the same rubric used for all sections of BIOC435.  All writing assignments 
are submitted electronically in Word format and the grading and comments on the papers are 
written with the “Track changes” feature. 
Oral presentation:  Students will give two presentations in class during the semester.  The first 
will be performed pair-wise as described for the research paper presentation.  This presentation 
will be given in PowerPoint format and the students will be able to use the chalk board to more 
thoroughly explain the methodology or data given in the PowerPoint slide.  The second 
presentation will be given solo by each student and the presentation will be timed so that there 
will be two presentations per class period.  The individual presentation is based on the review 
paper that will be completed or at least in rough-draft form.  The students will also present this in 
PowerPoint format as a clean articulated speech that summarizes what they have written in 
their review papers.  Evaluations for all presentations will be performed by their peers as well as 
the instructor.  The evaluation sheets are found in the syllabus.  Copies of the PowerPoint slides 
are retained by the instructor. 
Ethics:  Two class times during the course are devoted to ethics in scientific research practices.  
The first class period is a lecture on some of the prominent issues that are plaguing the field, the 
cost of misconduct, and solutions to some of the problems that arise in the ethical arena.  The 
second class period is a time when some of the students will be selected to give their opinion on 
several real-life case studies that the instructor will give them at the end of the prior lecture.  
Assessment on the ethics section of the course will be given during the second exam which will 
also cover the last half of the topic lectures. 
Analysis of Student Learning 
Quantitative Assessment of subject matter 
Exams:  The course is composed of twelve lectures that I design and present at every other 
class time during the first half of the semester.  The subject matter is glycobiology and pertains 
to everything from basic sugar chemistry to enzymes that build complex oligosaccharides on 
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proteins and lipids.  Nearly all of the material is new to the students as it is not covered in 
previous biochemistry courses.  There are some connections with previous work when I allude 
to more commonly known pathways such as glycolysis and the TCA cycle, but then I take 
tangential pathway that is not known to them.  An example of new biochemical pathways that 
originate in material covered in previous courses is the sorbitol and GFAT pathways that diverge 
from glycolysis.  To assess their comprehension of this new knowledge, I use exams comprising 
of T/F, multiple choice, short answer, and matching activities.  Examples of exams are in 
Appendix II. 
Quizzes:  The class day after each research presentation is a lecture.  Before the lecture 
begins, I hand out a quiz with 2 or 3 questions pertaining to the research paper that was 
presented in the previous class time.  The students get 5 minutes to take this quiz and it just 
assesses whether they took the time to read and understand the research paper. Examples of 
quizzes are in Appendix II. 
Qualitative Assessment 
I asked the question at the end of exam #2 to compare this course with other biochemistry 
courses as 1) Tough, 2) slightly harder, 3) average, and 4) easier and to give the reason for 
their answer.  Of the 22 responses, 20 of the students said this course was tough or slightly 
more difficult than previous courses.  Only two students said that the course was about the 
same and no one said this course was easier. 
Student feedback 
1. Tough; The level of details need to know are harder 
2. Slightly harder; Because of paper, presentations and difficult exams.  Most classes don’t 
have papers and presentations. 
3. Tough; The material is somewhat more involved.  There is simply more facts to know in 
our tests.  Additionally, we have less guidance as to which facts are important and worth 
studying.  Maybe a class statement of expectations such as a study guide would help. 
4. Slightly harder; Because the content is less familiar and there are not as many activities 
to help us retain the info in class. 
5. Slightly harder; As expected, this material is quite a bit more advanced than other 
courses.  I feel although my first test score didn’t show it, I did learn a lot of new 
information from the lectures. 
6. Tougher; Much more detail required to do well on exams. 
7. Average; no comment. 
8. Tougher; Only because most of the subject matter is new to me.  Prior to this, I knew 
more chemistry than biology. 
9. Tougher; The notes given in class are not always effective for studying – can be a bit 
“bare bones” for later review.  Harder to determine what will be important for exam.  Not 
my area of expertise. 
10. Slightly harder; no comment 
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11. Tougher; The other biochemistry classes were actually easy and straight forward maybe
because this is such a foreign topic and I am missing some of the specifics that bring
everything together.
12. Tougher; The long term planning for the research paper and the time that is needed to
be put into class was a bit overwhelming.  The lectures were challenging at times, which
is a good thing because I learn a lot about sugars.
13. Slightly harder; Usually for bioclasses, some of the material has been previously
covered, so its expansion of old topics + some new material.  This class is all new
material for me.
14. Slightly harder; It is slightly harder (just slightly) because the exam important material is
not 100% clear.  Also, they post study guides.
15. Average; This class is not ridiculously hard.  It demands an average amount of studying,
and perhaps a bit more outside research.  However, the quality of information is top-
tiered compared to others because it is relevant and up-to-date!!
16. Tougher; The content of the course is very specific and I have never been exposed to
almost anything taught in this class before.  The term paper is also demanding,
especially if we were given a topic we weren’t too interested in.
17. Slightly harder; The content was much more specific for this class, almost like a
graduate course, whereas previous BIOC classes have been quite general.
18. Slightly harder; Because it’s not just exams and quizzes.  Its also papers and
presentations which are not required in a lot of the courses I take so its more difficult
sometimes and more time consuming.
19. Tougher; Not a lot of reasoning is required.  I just try to memorize everything, because
the tests require me to do so.  I am not good at memorizing so many facts.
20. Slightly harder; While material was presented in a similar manner, the tests covered it in
more detail than other classes.
21. Slightly harder; This course involved in-depth analysis of research papers (never did this
in other courses) and being able to present the data.  The class also went into depth on
several sugar modifications, pathways and details (only did broad overview).
22. Tougher; All the content of the course are kind of new to me.  It is not easy to
understand as many complicated concepts and processes were involved.  This also
requires a lot of memorizing.
Assessment of critical thinking 
One of the goals of this course is to help students understand the primary scientific literature.  
Primary being the key word means that the students need to be reading research papers, 
understanding the methodology, and interpreting the data that was published.  I encourage the 
students to take a critical look at the question that is asked, the methodology used to answer the 
question, and the interpretation of the data generated using the experimental methods provided 
in the paper.  Usually differences in interpretation came down to the statistics that were used to 
evaluate the data.  
In the BIOC 435 course, critical thinking is assessed by two measures:  presentation of a 
research paper in class and writing a review paper covering a topic in the literature.  In my 
8 
specific section of the class, I also include a third measure by assigning the students abstract 
writing exercises over a redacted research paper.  I will cover the advantages, disadvantages, 
and outcomes for all three of these in the following sections. 
Presentation of research Paper 
On the first day of class, I ask the students to pair up or, if there are too many students in the 
class, form groups of three.  Sometimes the class is over-enrolled and more groups of 3 are 
necessary.  I present a list of research papers on the overhead projector and the student groups 
randomly pick a piece of paper containing a number out of a bucket.  Starting with number one, 
the student groups are able to choose their specific paper in orderly fashion.  Their assignment 
is to present the paper to the class, explaining the hypothesis, how they answered the questions 
presented in the paper, determine if the methodology was sufficient to answer the questions, 
and interpret the data.  The presenting students typically split up the workload “divide-and-
conquer” to carry out this assignment.  One student may do the introduction and methods and 
the other student may cover results and discussion.  Although, I tell them that they should not 
go over a research paper as they would read a novel, some student groups do that by starting 
on page 1 and going page by page through the paper.  This is particularly troublesome when 
they cover the methods.  I have had to intervene a few times to remind them exactly what to do 
and, perhaps, I take it for granted that I just assume that a good presentation is telling a story 
about the whole process from beginning to end.  The presentation typically takes the entire 
class period and the students are encouraged to ask questions throughout the presentation. 
Strengths of this activity:  The students that present the paper obviously learn the most from the 
exercise.  They are the ones who have to answer questions asked by their peers or myself.  
They do not want to look foolish in front of their peers so the vast majority of them really take the 
time to analyze the paper and the written details.  Some students have come to me to ask for 
assistance on parts of the paper that they did not understand.  This activity also puts the 
students in front of the class to give a presentation using PowerPoint.  Although not all 
instructors encourage the students to use PowerPoint, I feel that this format is most relevant for 
their future careers and how they will need to make presentations.  The presentation is worth 
10% of their overall grade.  The grading is done by peer-review with the following rubric 
Fig. 1:  Evaluation sheet for research paper to be filled out by the students. 
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Weaknesses of this activity: I have found that many of the students (those who are not 
presenting) do not read the paper before class.  They just come in and expect the presenters to 
teach them whatever is needed to know that day.  In response, I have developed quizzes to test 
if they even read through the paper.  Typically, I would show some data from the paper and ask 
them to interpret it or ask them about the model organism used and why it was used, or the 
hypothesis, etc.   I have noticed that the quizzes have encouraged the students to at least go 
through the paper and understand all of the figures and basic methods and questions posed by 
the authors.  I don’t think I will be able to get all of the students to read the entire paper unless it 
was a major component of an exam.  As a major exam component, I think it would be counter-
productive to do this since more of their time should be spent on the review paper and other 
activities in class. 
Writing a review paper (Appendix III) 
On the first day of class, my first lecture covers the differences between a research paper and 
review paper.  The ideas behind writing a review paper is that it will force the students to go 
through the databases (PubMed, Google Scholar, Web of Knowledge, etc) to find papers, read 
them, sort through the information, and write up a paper that covers the topic area of their 
choice.  Their choices are limited to a list of subjects I present on the first day, and like the 
research paper presentation, they pick a random number and then, in numerical order, pick from 
my list of topics.  They are usually confronted with a topic they have no knowledge about or one 
that they don’t particularly like.  In response, I tell them to make it interesting by choosing many 
research papers and build on themes, controversies, etc to formulate a story.  Most of the topics 
are covered briefly in one of my twelve lectures, though they are expected to take it step further 
and really dive into the subject matter.  The review paper consists of an abstract, introduction, 
three or four chapters/sections, and then conclusions/future perspectives.  The paper is graded 
by the rubric in Appendix I. 
Strengths of this activity:  Those students who want a good grade really dig deep in the 
literature and find many papers from which to tell a good story.  It is up to the students to put 
this paper together and make it as good as possible.  To assist them, pieces of the paper are 
turned in over the course of the semester.  For example, their outlines are due several weeks 
after topic selection.  The introduction is due 2 weeks after the outline.  Chapter 1 and the entire 
rough draft are submitted to me in similar manner over the course of the semester.  This 
prevents the students from procrastinating and waiting until the very end of the semester to start 
working on this paper which would never work in their favor.  This also allows me, as the 
instructor, to determine if they are on the right path or if they should change the course of the 
paper.  The submission and return for the paper is all electronic and in MicroSoft Word.  I 
receive the manuscripts, and use the “Track Changes” feature in Word to make corrections and 
suggestions for improving the paper.  Usually, my instructions are received and adapted; 
sometimes they are not.  The students are given a lot of latitude to be creative and find material 
that I do not know about.  This happens frequently in which I am surprised that the student has 
taken the angle of an argument I had not considered or found an area in biotechnology that I 
was not aware of and made a sensible scholarly piece of work. 
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Weaknesses of this activity:  It is impossible for the instructor to check all the references of each 
paper to ensure that the students read the paper correctly and understood the data.  I suspect, 
and it has been confirmed by their written work, that many students read the papers superficially 
and pick and choose only what is needed.  As a member of the research community, I am guilty 
of this as well in which I will only consider one figure or read just the abstract of a research 
paper that I will cite in my own paper or grant.  Many, if not most, of these students probably do 
the same thing when reading papers for their review paper.  I feel that many students are 
missing out on the opportunity to really analyze the details of papers and evaluate their merits.  
This is reflected in their final draft of the paper in which much of it appears to be superficial.  
Another weakness that I have found with the review paper is that I cannot really assess their 
writing until they turn in the introduction which occurs about half way through the semester.  
This delay limits instruction in this area. 
Writing an abstract (Appendix IV) 
I feel that this activity is the most useful for assessing their critical thinking.  During the first half 
of the semester, I present the students with three papers that have been redacted as a PDF 
document (Fig. 2).  This means that all identifying information of the paper is deleted including 
title, authors, abstract, and journal identifiers.  The students get the introduction, methods, 
results, and discussion.  From these sections, they need to write an abstract for the paper in the 
paradigm that they are the author.  Normally, the abstract is written last so this is a very real-
world simulation for analyzing the data and writing a short, easy-to-read, and comprehensive 
summary. The topics of the paper are not overly complex and do not need to be in the subject 
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area of the class.  This activity is worth 10% of their final grade.
Strengths of this activity:  Since these are papers that I have selected and know, it is easy to 
determine whether or not the students understood the paper.  This exercise also puts them in a 
position to write what they have interpreted from the data and either draw their own conclusions 
or agree with the authors of the paper.  The abstract needs to be between 200 and 300 words 
so it is limited to one page.  This is a good assessment of their writing abilities in addition to 
critical thinking.  I get a good sense within the first few weeks of class which students are strong 
or weak in both thinking and writing.  I often find that the students will understand the paper, but 
are not able to convey that understanding to written language.  I believe that is a common 
problem throughout many disciplines. 
Weaknesses of this activity:  From the student perspective there are no weaknesses in this 
activity.  I have polled the students and most say that this activity has helped them to 
understand research papers and to evaluate their own writing activity.  The weakness lies with 
the instructor in that it is immediately clear who is good, mediocre, or lousy at technical writing.  
I have been using the rubric for review paper to grade these abstracts, but I feel that I need to 
refine the rubric for this specific activity.  I have considered peer grading, but have not applied it 
since most of the students do not know what a good abstract should contain.  I have entertained 
the idea that I should allow a revision for those abstracts that have poor scores.  This has not 
been applied to the class, but there may be some benefit in that the student will be able to go 
back and take a second look at the paper in addition to some of my comments and identify the 
weaknesses of their work. 
Fig. 2  On the left is an example of a research paper downloaded from the Journal of Biological Chemistry.  On 
the right is the same paper with the identifying information deleted including the abstract. 
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Assessment and Outcomes of the Class Activities and Organization 
From an instructor’s perspective, it is difficult to know what class activities really 
contributed to the student’s learning and critical thinking exercises that made a lasting 
impression and would be something that they would be able to apply to their lives outside of 
class.  Writing is a major component of the class and the quality of penmanship varies widely 
among the students.  There were two major writing assignment categories; the review paper 
and the collection of abstracts.  The students were asked “What was more effective in improving 
your writing (Fig. 3)?” 
The majority of students thought that both assignments helped them in their writing followed 
closely by the abstract writing.  Only two students thought that the review paper alone improved 
their writing capability.  Clearly, the exercise of writing the abstracts was more beneficial for the 
students.  It may have been because these are short assignments that could be accomplished 
in a relatively short amount of time versus the review paper which is worked on during the entire 
semester. 
Since the abstract writing was successful in that the students thought they are useful 
and they get feedback from their work, I wanted to know how they felt about the balance of the 
workload.  In other words, should the class focus more on the review paper or the abstracts or 
strike a healthy balance between the two activities?  This is an important issue since this is an 
ACE 10 course and the Dept. of Biochemistry has made the case that the review paper is the 
scholarly product of the class.  From a department perspective, that seems like a good measure 
of student learning, however, is it really the best method for measuring critical thinking?  It 
should be remembered that the instructors do not have time to rigorously analyze each 
reference of their papers to ensure that the information that is referenced actually is reflective of 
the statements made in the papers.  In contrast, the papers used for the abstract writing are 
thoroughly vetted by the instructor and the student really needs to interpret the data to write a 
good abstract.  Both the review paper and abstracts are useful for student writing as seen in Fig. 
3, so what is a good balance?  The question was asked “What changes would you make to 
improve your writing skills (Fig. 4)?   
# of Respondants
0 3 6 9 12 15 18
Abstracts
Review paper
Both assignments
Fig. 3:  Polling results of the question 
“What was more effective in improving 
your writing?” 
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 From the responses given in Fig. 4, the majority of students favored writing a shorter 
review paper and double the number of abstracts assigned.  What is striking from the poll, is 
that none of the students chose the option, “No abstracts/10-12 page review paper” which is 
how the other BIOC 435 sections are organized.  It is likely that the review paper is a long 
tedious assignment and is viewed as “something that is continuously worked on” with few 
rewards.  As one student put it “[This was the] first time writing review/research paper, so it was 
very foreboding/intimidating”.  Currently, the review paper is the only “scholarly” product from 
the course.  Perhaps, the scholarly product from the course could be a portfolio containing a 
mini-review and a collection of abstracts including the PowerPoint material from their 
presentations.  This is an issue that would need department approval and a formal change in 
the course outcomes on the college level. 
 At the beginning of the course, I often ask the students by show of hands how many of 
them know about the PubMed data base and have they read a scientific paper.  Most students 
affirm that they have used PubMed, although their experience is limited.  This is their first 
course in which they have to really dig into this and other databases and gather a collection of 
papers for their review paper.  For writing a good review paper, they do need to understand 
what is written in the research papers.  I polled the students and asked which of the two writing 
activities improved their reading comprehension (Fig. 5). 
 
 # of Respondants
0 3 6 9 12 15 18
           
Leave the course as presently organized
6 Abstracts/4-5 page review paper
12 Abstracts/no review paper
No abstracts/10-12 pg review paper
2 shorter (4-5 pg) review papers
 # of Respondants
0 3 6 9 12 15 18
        
Research papers for writing abstracts
Research papers for review paper
Both had equal contribution
Fig. 4:  To balance the writing 
activities of the course, the 
polling question was asked; 
“What changes would you 
make to improve your writing 
skills?” 
Fig. 5:  The poll question 
was asked, “Which writing 
activity improved your 
reading comprehension?” 
14 
 
The poll results in Fig. 5 indicate that although the abstract writing is valuable in reading 
comprehension, the activity of perusing many papers in the databases has value. Nearly half 
the students thought that both writing activities had value for improving their reading 
comprehension.  Results from this question and the previous as shown in Fig. 4, suggest that 
the research paper alone is not sufficient for student reading comprehension, therefore, the 
combination of activities is really beneficial for the students’ critical thinking of activities. 
As stated previously, the presentations by the students take up most of the classroom 
activity.  They share 50% of the class time during the first 2 months of the semester and then 
after that, their presentations take up 100% of the class time.  The instructors typically have to 
give about a dozen lectures during the whole semester.  Since their presentations consume 
most of the class time, I asked if they were useful for their learning (Fig. 6). 
 
As seen in Fig. 6, the vast majority of students felt the presentations were a useful 
component of the class.  Some comments were:  
• “It gives us a feel on how to read and analyze these documents.  That way you 
get a bigger understanding and it makes you ask questions”.   
• “It forces you to work with other person which is a necessary skill, but it also 
ensures that you are self-reliant and able to comprehend and communicate 
material effectively.” 
• “It was helpful to get in front of the class to speak.  Especially if that’s something 
you’re not very comfortable doing.  This is a good environment to get 
experience.” 
• “Practice public speaking and learn from peers.” 
• “This allowed me to focus on the really important parts of these papers to present 
to the class.” 
There were a few students that did not think they were useful, but I suspect that is 
because they were not comfortable with standing in front of a class and the focus of attention.  
As two students put it “The presentations made me nervous” and “ I get a great deal of anxiety 
over presentations and sometimes felt like I didn’t get enough direction, they weren’t useful for 
me.”  It is understood that some of the more introverted or “shy” students would have a more 
 # of Respondants
0 3 6 9 12 15 18
     
Yes
No
Fig. 6:  The students were asked in a poll 
if the presentations were useful for their 
learning activity. 
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difficult experience with class presentations, nevertheless, it is a useful activity and valuable for 
their professional career development as they will need to stand before people and speak to an 
audience.    
The last outcome that the students were asked were about the exams.  Presently, the 
exams only cover the instructor’s lecture material presented in PowerPoint format.  Each 
student gets a paper copy of the slides during the day of lecture and all the material is available 
electronically via BlackBoard.  Nearly all of the lecture material is new to the students and many 
of them seem to have difficulty learning all of it.  Consequently, the exam scores tend to be low 
with the average in the mid to low 70th percentile.  This seems to discourage the students as 
well as myself in that the exams traditionally have high priority in a class, but these exams wore 
the students down and exams are not one of the critical outcomes of the course.  The scores 
were better when the exams covered 4 lectures and worse when the exam covered 6 lectures.  I 
think that the amount of material is overwhelming them and I may have re-think of how to format 
these assessments.  The lecture material is important since it provides some foundation 
material for both their papers and their presentations.  Since instructors are not usually experts 
in exam writing, I asked the students how they would improve the exams (Fig. 7). 
The results from this poll favored a take-home exam for analyzing one or more research 
papers closely followed by the present format.  The right way to assess their learning ability may 
be a combination of these activities to assess their knowledge and critical thinking.  In essence, 
the current abstract writing activity closely follows this activity as exam material since it is 
graded.  For an exam, I would need to ask specific questions about the paper and then they 
would need to answer these on an individual basis.  As take-home exam material, this would 
mean that each student would need a different paper and that would result in a sharp increase 
in work on part of the instructor.  Good exam writing and assessment is still under development, 
but a balance of the current format with critical thinking from interpreting a paper is achievable.   
Student Opinion of the Course 
# of Respondants
0 3 6 9 12 15 18
Status quo of present format
Take-home exam analyzing research papers
Present format in the testing center
Exam in the testing center analyzing 
several research papers
Fig. 7:  A poll question was 
asked “How would they[the 
students] improve the exams. 
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After multiple teaching experiences over the past 3 years, I am curious how the material 
was received since each class is different in student composition and preparedness.  I gave a 
survey to the students and asked them what worked well (things to keep), what did not work 
very well (needs to stop) and which parts were the easiest and most difficult.  These were all 
open-ended questions so the responses were variable.  I will summarize what I found to be the 
trends. 
What is working: Many students felt that all aspects of the course working together had the most 
benefit for them.  The subject material was new and not taught in any of their previous courses 
so it was not just a recycling of familiar material.  They also liked how the lecture material dove-
tails with the research paper presentations and that the lectures also give background material 
for their papers.  The abstracts and review paper were well-received and most students thought 
they were both challenging.  The following quotes are from the survey. 
• “I enjoy all aspects of this class and the professor is great.  There is an actual focus on
our learning and is centered around preparing us for the professional world.  I feel this
class prepared me more for my future than most of my other courses.”
• “I like that we turn in the final paper in segments so we get feedback on our writing
throughout the course and not just at the end.”
• “I thought the class was great, although it was challenging, it helps combine all my
knowledge in one great whole.”
What is not working so well.  The major complaint of the course was the exams and how 
difficult and detailed they were.  Since this was their first exposure to this material, this opinion 
is valid in that maybe I demanded too much.  I had noticed that when the exams covered four 
lectures instead of six, that the students did better and did not complain about them so much.  
To remedy this, I may have to go back to doing four lectures/exam instead of six/exam.  The 
second biggest complaint is the time it took to research and write the review paper.  As this is a 
major component of the course and the outcomes for ACE 10, I cannot realistically take this out 
of the course.  I may be able to fine-tune it better by having them hand in more parts of it on a 
regular basis, though I am already having them turn it in four pieces that are marked with my 
comments for improvement.  Concerning the research presentations, one student noted what I 
had suspected of these presentations.  He/she had written “The group presentation over the 
research papers didn’t fulfill their purpose.  Most of the students only read the paper they were 
assigned to present and class discussions didn’t really happen.”  This has been a real 
challenge in the class in that I am trying to balance how much leadership the students take in 
their presentation and how much I need to get involved with leading the discussion.  Since each 
student group is different and I do not know these students very well on a personal level, it is 
difficult determine when they need a bit of help and stimulation versus me taking over the class.  
The last thing I want to do is take their presentation away from them by leading the discussion. 
What part of the course was the easiest?  Many of the students felt that the presentations were 
the easiest, specifically, the solo presentation on their review paper.  The second most popular 
answer was the quizzes on the research paper presentations.  Other more scattered answers 
included the abstracts, the exams, or writing the paper. 
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What part of the course was the most difficult?  The most popular answer to this question was 
the exams.  As seen from Fig. 7, I may introduce more critical thinking exercises on the exam 
and ease up a bit on the lecture material.  Doing this would serve the students better, though I 
have yet to test this.  The second most popular answer was writing the research paper.  
Several students mentioned that they found it difficult to take a wide assortment of papers and 
collate them into one seamless document.  This was supposed to be alleviated when they write 
up an outline and go over the material with me in my office in a face-to-face discussion. 
Results from the Just-In-Time Teaching (JiTT).  Throughout the twelve lectures, four questions 
were posed the night before the relevant lecture to get the students to research a question and 
find a suitable answer.  The results of answers were given during the lecture the following day.  
Overall, the questions forced the students to look up material and many of them stepped up to 
the challenge and referenced papers in their pursuit of an answer.  The four JiTT questions are 
as follows: 
A) High Fructose corn syrup in many products that we eat and drink.  Is it good for us, bad for
us or neither good nor bad for us?  Explain your answer. 
B) What is caramelization and explain some of the chemistry that is going on?
C) How does Mucinex work?
D) Imagine that you have discovered a protein and determined the sequence.  The amino acid
sequence reveals that 8 sites may be modified by substrate #1.  Those same 8 sites may also 
be modified by substrate #2.  How many different species of this protein would be possible if 
only substrate #1 was allowed to act on the protein?  How many different species of this protein 
would be possible of both substrates 1 and 2 are allowed to act on this protein? 
Participation in each of these activities was over 80% and at least half of the students 
were able to get the correct answer.  Interestingly, the math and biochemistry dual majors 
missed the 4th question, the only one that involved any mathematical knowledge.  Did these 
activities result in a deeper understanding of the subject material?  Yes, because they were 
more prepared for class and had some idea of what the lecture would be about.  Did it help 
them in the exams?  No.  The exams did not cover the exact material and it is common for 
students to compartmentalize information.  The students did enjoy looking up the material, 
although one student did dissent and asked that the participation activity cease.  In future 
courses, I plan to develop more carefully crafted questions that require more thought and 
expand the number to 6 questions or about 1 per week for the first half of the semester during 
my 12 lectures.  Details of how the class answered the JiTT questions may be found in 
Appendix V.  
Planned Changes 
Based on student feed-back and what I have noticed to be deficiencies, I plan to: 
• Increase the number of abstracts to be written from 3 per semester to 5 per semester.  I
may also increase the percentage of the grade for the abstract written material from
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10% to 15%.   I am still considering but not sure of adding the abstracts to a portfolio of 
scholarly work that the student will submit with the paper.   
• Reduce the amount of questions on the exam so they may be completed within 30 min.
and introduce a paper on the exam for them to interpret the data in its presented form.
This type of format will still allow me to cover the necessary subject matter and assess
their critical thinking skills.  I may also reduce the exam percentage of the overall grade
from 30% to 25%.
• Keep giving quizzes on the research paper, but include data from the paper that is
needed for interpretation.  Hopefully, this will stimulate the students to at least look at
the figures in the papers and understand them.  I also plan to ask a question or two on
any controversial material that was presented in class as part of the student
presentation.  Currently, quizzes are worth 5% of the grade with the allowance of
dropping the two lowest scores.  I will keep this format.
• The research paper format and length will not change even though students would like
to write a shorter paper.  I will need to emphasize that writing the paper in a series of
small portions will lead to a comprehensive scholarly work by the end of the semester.  I
do believe that the students just feel overwhelmed when they first see the work that is
required at the beginning of the semester.  It is all psychological.
• Expand the number of JiTT questions based on the lectures.  These are always good to
see what the students know and how they tackle problems.  It also serves as a guide on
what I need to emphasize in lecture and that emphasis may increase their
understanding and exam scores.
• Develop a more comprehensive rubric for grading the written abstracts.  So far, I have
used the rubric for the research paper, but it does not fit quite right and I have been
grading on sort of a qualitative scale.  This does not seem really fair to the students and
this new rubric will be implemented before my next class.
Summary and Overall Assessment of the Portfolio Process 
Throughout the process of collecting the information for this course portfolio, I have 
realized that I am basically on the correct track in teaching this course, but a few refinements 
and modifications will make this course even better and more seamless on my part.  I need to 
exploit some of my current methodology to make a bigger impact with their learning.  One way 
to do this is to develop better JiTT questions for the subject material.  The type of question and 
how it is asked can really make or break this exercise.  A second way for making a bigger 
impact for the assessment of critical thinking is to put more critical thinking exercises on the 
exams.  Some evaluations have mentioned that my exams are too memorization intensive and 
that may be true, but the real emphasis of this course is critical thinking skills and not rote 
memorization of facts and figures.  I have always been too content driven in this course and not 
enough emphasis has been placed in the “process” of learning.  I will need to slow down in my 
lectures and not worry if I hit every point.  Although I ask the class if there are any questions at 
the end of lecture, I rarely need to take a question because all of them are too afraid to ask and 
look “dumb” in front of their peers.  Those students that I “lost” during the lecture will never 
speak up at the end of class, though few have asked me to re-explain something during the 
lecture.  
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I have realized that over the past 3 years of teaching this course that the students come 
in all variations of writing and reading abilities.  How to manage this diversity of skill and keep 
everyone enthusiastic about the course has been a real challenge for me.  I hate it when 
someone mentally drops out because it is too difficult or too easy in some cases.  I implemented 
a wide variety of activities early on so that if a student “bombs” a test or presentation, the grade 
is salvageable.  From my own experience, I have done poorly in some parts of a class and was 
relieved and encouraged that it was redeemable.  I try to do that in this class, while maintaining 
focus on the course objectives.  I don’t expect every student to exit the class as an expert 
technical writer, but I would like every student feel that he/she has accomplished something (i.e. 
the review paper) and know that through this experience they are better at technical reading and 
writing than when they entered the class.  This is what I count as success in this course. 
In revisiting my portfolio objectives from page 1, I will answer what I realized throughout 
this whole process. 1) how are my teaching refinements and activities improving the course?  
The introduction of abstract writing in the course and accountability for reading papers via 
quizzes is an improvement.  Refinement for teaching these students how to read and write is an 
on-going process, but I think it is mostly complete.   2) Are my assessment methods for 
evaluating student learning during the semester sufficient?  Yes, though I am able to improve in 
this area with my planned changes outlined earlier.  3) Is my course meeting all of the 
requirements for ACE 10? Yes it is.  My methods exceed the department’s requirements, 
though it is more effort on my part.  I feel it is my responsibility, as a professor, to prepare the 
students to meet the challenges in post-college life.  The principles learned in this course may 
be transferrable to any professional career. 
Appendix I 
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Biochemistry 435 Advanced Topics in Biochemistry 
Course Focus: Glycobiology 
Spring 2014 Syllabus 
Instructor: Edward N. Harris, Ph.D. 
N133 Beadle, 472-7468, eharris5@unl.edu 
Office hours (Beadle N133) email/call me to set up time. 
Class times: M W F 8:30 am to 9:20 am in Rm N177 Beadle 
Prerequisite: Bioc 432 and major in biochemistry 
Your Course Objectives 
• Integrate overall biochemistry knowledge and understanding with emphasis in sugar biochemistry.
• Learn to read and critique the primary literature and experimental methods in biochemistry.
• Become acquainted with sophisticated topics in biochemistry and able to contribute to group discussions
about the literature related to these topics.
• Apply your biochemical knowledge to new areas within the life sciences.
• Organize and present biochemical research data in oral and written formats.
Text (suggested as a reference only):  Essentials of Glycobiology, 2nd Edition found at 
http://www.ncbi.nlm.nih.gov/books?term=essentials%20of%20glycobiology 
We will use research articles available on the Web and in the University Libraries 
Activities: 
• There will be class discussions of assigned papers.  It is assumed that each student will have carefully
read the papers and reflected on them prior to the class. 
• Students will be active participants in class discussions and evaluate their peers on their presentations of
scientific papers. All students will read the articles and participate in the discussion, but the presenters 
will lead the discussion.  
• Students will present a 20 minute presentation of their chosen topic which will be a summary of their
review paper. 
• Each student will write 3 abstracts for research articles over the course of the semester.
• At the end of the semester, each student will submit a review article containing an abstract, introduction,
chapters/topics of discussion, future directions, conclusion and references.  The paper should contain
references from the scientific literature.  Web sources are neither peer-reviewed nor stable and are not
generally valid citations.  The syllabus contains the rubric that the instructor will use in evaluating final
paper.  The paper should be at least 8 pages long (excluding references), single spaced, font size 11 in
Times New Roman or Ariel.
• Classroom participation
Grading: 
• Students will take 2 exams covering 6 topics during the semester.  Each exam is 15% of the grade.
• Students will receive numerical grades at the end of the semester for the final paper.
• Short quizzes consisting of two to four questions will be administered to the class time after the
discussion of paper as indicated on the course schedule.  The quizzes will cover material the research
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paper and are designed to ensure that students have the skills to read and understand research papers.  
These quizzes will be 5% of the overall grade.  A student is able to drop 2 of the lowest scoring quizzes 
by the end of the semester. 
• The completed paper is worth 25% of the final grade.
• The presentation of the review paper is worth 10% of the final grade.
• Evaluations and presentation of research papers is worth 10% of the final grade.
• Participation in class activities is worth 10% of the grade.
• During the semester, three research papers will be given and student will need to write a coherent
abstract/summary statement (200-300 words) for each paper.  Student will be given 2-3 weeks for each
paper.  This is worth 10% of the grade.
• Grading scale: 100-93, A; 92-90, A-; 89-88, B+, 87-83, B; 82-80, B-; 79-78, C+; 77-73, C; 72-70, C-;
69-68, D+; 67-63, D; 62-60, D-; 60 and below, F.
Notes: 
• On Jan 30, the students will turn in an outline of their paper.  This will include a title and 3-5 topics of
discussion.  This should not exceed 1 page.  The instructor will also be available to meet with students (one 
on one) during office hours or during appointments (Jan 30-Feb 4) to discuss the outline and direction of the 
paper.   
• On Feb 15, the students will turn in their introductions for their paper with revised topic headings for
discussion.
• On March 25, rough draft of the papers will be turned in to the instructor and students will be given an
opportunity to discuss issues with the instructor.
• The final presentation of the paper will be limited to a 20 minutes followed by 5 minutes of question &
answer
Schedule: 2014 BIOC 435 Class 
Date Subject Action items 
1/13 Syllabus, How to write a paper, lit search 
1/15 Short talk, how to write abstracts Topic selection, research paper 
selection 
1/17 Topic 1: General info on sugars 
1/20 No Class 
1/22 Topic 2: High fructose corn syrup 
1/24 Discussion of Research Papers 
1/27 Topic 3:  advanced glycation end products/mall rxn quiz 
1/29 Discussion of Research Papers 
1/31 Topic 4: Glycosyltransferases quiz 
2/3 Discussion of Research Papers 
2/5 Topic 5: N-glycans quiz, Outline of topic due 5 pm 
2/7 Discussion of Research papers Discuss outlines in office visits 
2/10 Topic 6: O-glycans, quiz 
2/12 Discussion of Research papers     Abstract 1 due 
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2/14 Exam 1 
2/17 Topic 7: O-Fuc quiz 
2/19 Discussion of Research papers 
2/21 Topic 8: O-GlcNAc quiz, Introduction due, 5 pm 
2/24 Discussion of Research papers 
2/26 Topic 9: Chondroitin sulfates/Heparin/HS quiz 
2/28 Discussion of Research papers 
3/3 Topic 10: Hyaluronan quiz, Abstract 2 due 
3/5 Discussion of Research papers 
3/7 Topic 11: Lectins quiz, Chapter 1 due, 5 pm 
3/10 Discussion of Research papers 
3/12 Topic 12: Lectins II quiz 
3/17 Discussion of Research papers 
3/21 Ethics quiz, Abstract 3 due 
3/23-30 Spring Break 
3/31 Ethics 
4/2 Exam 2 
4/4 Student Presentation 
4/7 Student Presentation 
4/9 Student Presentation Rough draft due, 5 pm 
4/11 Student Presentation 
4/14 Student Presentation 
4/16 Student Presentation 
4/18 Student Presentation 
4/21 Student Presentation 
4/23 Student Presentation 
4/25 Student Presentation 
4/28 Student Presentation 
4/30 Student Presentation 
5/2 Student Presentation Paper due, 5 pm 
5/5 No class 
5/7 No class 
Topics for the Review paper and presentation  
HA synthases in cancer biology 
HA in bacterial pathogenesis & disease 
HS/HP biosynthesis enzymes 
O-GlcNAc modifications in human disease 
O-Fuc modifications and protein function 
Role of Mucus/Mucins 
Role of Galectins in cancer 
Sugar substitutes (Aspartame,  Saccharine, etc) and health impacts 
Effects of high fructose corn syrup on obesity/diabetes 
Heparin for human therapy and treatment of disorders 
Impact of (exogenous) advanced glycation end products on health  
Impact of (endogenous) advanced glycatio end products on health 
Effect of O-GlcNAc on gene expression 
N-glycosylation disorders 
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Role of Selectins in inflammation 
Arthritis and hyaluronan 
Bacterial glycomolecules and disease mechanisms 
Viral glycans/enzymes and disease mechanisms 
Protozoan glycans and disease 
Helminth glycans and disease 
Glycan storage diseases 
Beta-glucans and the immune system 
Type I diabetes (cause, mechanisms, treatment) 
Type II diabetes (cause, mechanisms, treatment) 
Honey in therapeutic treatments 
O-mannosylation related disorders (Muscle-eye-brain disease, Walker-warburg syndrome, etc.) 
C-mannosylation:  What is it and what does it do? 
Carbohydrates in biotechnology 
 
Special Needs  
Students with disabilities are encouraged to contact the instructor for a confidential discussion of their 
individual needs for academic accommodation. It is the policy of the University of Nebraska-Lincoln to provide 
flexible and individualized accommodation to students with documented disabilities that may affect their ability 
to fully participate in course activities or to meet course requirements. To receive accommodation services, 
students must be registered with the Services for Students with Disabilities (SSD) office, 132 Canfield 
Administration, 472-3787 voice or TTY.  
Academic Honesty: 
Academic dishonesty includes fabrication, falsification and plagiarism and will not be tolerated by CBC faculty 
and should not be tolerated by CBC students.  Falsification of research data or its deliberate misinterpretation is 
a serious offense.  Cheating on an examination or assignment is an obvious form of academic dishonesty.  
Plagiarism is more complex and may be the result of sloppiness, rather than an intentional attempt to deceive.  
Plagiarism is defined as passing off someone else's ideas, words or writings as your own.  Inclusion of a 
sentence in a paper that is copied from any source without quotation marks and citation is an example of 
plagiarism.  Anything that you present that is under your name should be entirely your own work unless so 
indicated and appropriately cited.  This includes ideas as well as specific quotations, artwork and figures.   
 
Some biochemistry students do not realize that they have copied whole sentences out of published work when 
then write papers.  To help you determine if you have inadvertently done this, we can submit your written work 
through the Safe Assignment feature in BlackBoard. 
 
Guideline for Literature Search 
 
1. Search literature  
• Textbook – to acquire basic information and cited reference papers  
• PubMed (http://www.ncbi.nlm.nih.gov/pubmed) literature search database 
• Web of Knowledge (Google it, then bookmark it) 
• Visit home page of journals  
     (e.g., “Annual Review” series, http://www.annualreviews.org/)  
• Type key word(s) of your interest  
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If you like to select only review papers, type “review” along with key word(s).(e.g.,Heparin, synthase, 
review) 
 
2. Download articles 
(1) How: 
• Article published in a few journals are freely accessible.  
• University subscribed journals - Download via the UNL library system 
• Must use a UNL-connected computer. 
• Use interlibrary loan for articles that cannot be obtained freely. 
 (2) Format: 
• Full text - High resolution figures can be downloaded along with text 
• PDF format - requires “Adobe Reader” to open the file 
 
3. Examples of journals publishing high-quality review papers in biomedical sciences 
• “Annual Review” series - http://www.annualreviews.org/ 
• (2) “Nature Review” series - http://www.nature.com/reviews/index.html  
• (3) “Current Opinion” series - http://www.current-opinion.com/journals/default.aspx 
• (4) “Trends” series - http://www.cell.com/cellpress/trends 
 
4. Examples of journals publishing high-quality primary research papers in biomedical sciences 
• “Nature” series - http://www.nature.com/  
• (2) “Science” - http://news.sciencemag.org/  
• (3) “Cell” series - http://www.cell.com/cellpress  
• (4) “Proceeding of the National Academy of Sciences” - http://www.pnas.org/ 
• (5) “The EMBO Journal” - http://www.nature.com/emboj/index.html 
• (6) “Journal of Biological Chemistry” - http://www.jbc.org/ 
 
5. Selection of significant papers  
• While it is controversial, journals with a high impact factor publish significant papers.  
• (2) “Impact factor” is a measure of the frequency with which the average article in a  journal has been 
cited in a particular year.  
• (3) How to search the “impact factor” of each journal 
Search for the Journal Citation Reports (JCR) in the context of specific field or 
   journal title -  http://admin-apps.isiknowledge.com/JCR/JCR  
 
Guideline for Reading and Presentation of Research Papers 
 
1. Paper discussion in class 
• One paper will be signed to two students. They will collaborate to present the paper and lead a 
discussion.  
• Given that we will discuss two papers per class, each paper discussion must be 
      completed within 20 min with a 5 min Q & A. 
• It may not be possible to cover all details of the paper during presentation time. It is also not necessary 
to discuss all figures and tables of the paper. However, integration of relevant information published in 
other relevant papers is highly recommended.  
• While the responsible two students will lead the discussion, all students should 
      thoroughly read the papers prior to the class and actively participate in discussion. 
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2. It is critical to figure out (or extract, synthesize) the following points when you read
   papers. 
• What are the question(s) addressed in the paper?
• What are the advance(s) made by the paper?
• Does the paper use appropriate methods and approaches to answer the question?
• Is data collection and interpretation accurate?
• Does conclusion reflect data?
• Significance and impacts of the research.
• You should be able to criticize the hypothesis, experimental methods and approaches, data collection
and presentation, interpretation and integration of data, and/or conclusion.
• You should be able to find out remaining unanswered questions about the research topic.
3. Major issues you need to care when you lead a discussion of a paper.
• Provide sufficient backgrounds.
• Let everybody know about the question(s) that are addressed in the paper.
• Briefly describe methods. However, if the methods are unique and/or critical for understanding
presented data, you may discuss in detail.
• Interpret (what message do you extract from the data?) rather than describe (what the data is?).
• Criticize presented data and interpretation by the authors.
• Emphasize the significance of the study and advance(s) made by the paper.
• Emphasize impacts of the data in the context of the same or related research fields.
• Identify interesting unanswered questions and provide research directions of the topic.
4. A common delivery method is a PowerPoint slide; however, any creativity is
appreciated, except Dance.
Useful background information has been and will be placed on the BIOC 435 BlackBoard 
 Biochemistry 435 is a Capstone course that meets the criteria for Area 10 of the 
Achievement Centered Education program for the University of Nebraska.  Below are the 
expectations related to the ACE outcome: 
SLO10: Generate a creative or scholarly product that requires broad knowledge, appropriate technical 
proficiency, information collection, synthesis, interpretation, presentation, and reflection.  
1. Describe opportunities students should have to learn the outcome.
How is the learning objective embedded in the course?
Students at the start of this capstone course generally have minimal exposure to the primary scientific
literature and to writing in a scientific style. This course focuses on one topic that cuts across the various
life science disciplines. Students receive a few lectures of introduction, and then start reading journal
articles selected by the instructor. Then, most of the remainder of the semester is comprised of students
searching the primary literature and collecting relevant articles with information to build a coherent
paper that proposes the direction of future research in one aspect of the general topic. Students learn to
make presentations of their selected papers and reflect on how the data reported represents an
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incremental increase in knowledge and understanding. The different sections of this course taught by 
different instructors may have different general topics. For the section taught by Dr. Cahoon, students 
explore metabolic engineering for the semester. Each student is assigned one metabolic engineering 
target and will explore its utility, biosynthesis, and devise a metabolic engineering strategy for 
producing the target compound in a recombinant host. The major focus of the course is the development 
of the course paper, but students also give a final PowerPoint presentation to the class.  Sections taught 
by other faculty follow a generally similar program, but the topic and specifics may vary. 
2. Describe student work that will be used to assess student achievement of the outcome and explain how 
the students demonstrate the knowledge and skills specified by the outcome.  
Students will develop a course paper on the particular aspect of the general topic for the course. The 
student will work on chapters that will build to form the summative paper. The chapters are turned in at 
three to four week intervals and receive formative assessment from the instructor based on a rubric. 
Students then have the ability to incorporate feedback into the development of the subsequent chapters 
and to rewrite the chapter already assessed for incorporation into the final paper. In addition to the 
continual assessment and feed-back related to the course paper, students provide self-evaluations at 
weeks 5 and 10 that are related to their degree of engagement with the primary literature and their 
contributions in the general discussions of student-presented papers that occupy most of the class 
sessions.  
3. As part of the ACE certification process, the department/unit agrees to collect and assess a reasonable 
sample of students' work and provide reflections on students' achievement of the Learning Outcomes for 
its respective ACE-certified courses. 
Please comment on your plans to develop a process to collect and evaluate student work over time for 
the purpose of assessing student success for this ACE outcome.  
The assessment will be bipartite. The instructor will save the self-evaluations and her/his comments on 
them as a measure of the degree to which the student's perception of their pro-active engagement in 
mining and presenting the primary literature is parallel to that of the instructor's perception. The second 
element is in archiving the students' chapters for the course paper in their original format with faculty 
annotations and suggestions, and the final course paper that was turned in for a final grade. The ability to 
compare the initial attempt to produce each chapter and the final work should provide evidence of the 
student's initial level of abilities at information collection, interpretation, reflection and synthesis, and 
the final level achieved by the end of the course.  It is proposed that the instructor select the above 
materials for the students receiving the top two grades, the two median grades, and the two lowest 
grades in the course to submit to the Department for archiving.  
Reinforcements 
According to the ACE document approved by faculty (Structural Criteria, item 9), "Every ACE course will 
reinforce at least one of the following skills listed below as appropriate for the discipline and as identified by 
the department offering the course..." Indicate skills that will be reinforced by the course by clicking on as many 
as apply and describe briefly how those skills will be reinforced. 
 
These areas are those OTHER THAN the one or two outcomes for which you seek ACE certification. 
Students will not receive ACE credit for the reinforced skills, and the reinforced skills do not need to be 
assessed for ACE purposes.  
What Outcome(s) or skill(s) will be reinforced in this course? 
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Writing 
Students will be writing in a scientific format for the first time. This may be very different from prior 
writing in the university. For example, it is common to use past-tense, passive-voice in scientific 
writing. Students will need to learn how to use and cite appropriate references from the primary 
literature. This will come from discussions in the classroom sessions and from feedback on the course 
paper chapters that are submitted during the progress of the course. 
Oral Communication 
This will be reinforced by the presentation of relevant papers from the scientific literature during most of 
the class periods. Students need to learn to master the content of such papers, prioritize the important 
elements, and present them in a coherent fashion. The student effort receives intrinsic feedback during 
the process by questions and comments from the instructor and from the other students. 
Critical Thinking 
Critical thinking can only be done once a student has mastered a significant amount of foundational 
literature. Students at the start of the topic will have little ability to carry out critical thinking about the 
course theme. As students read more of the primary literature and seek out other references to flesh out 
certain aspects and to reconcile contradictory reports, they will be encouraged to reflect on the 
epistemology of the conclusions. 
Ethics 
Each section of the class involves one class session related to an ethical issue. This usually involves a 
case study that is read prior to the class and a group discussion. In some cases, it is productive to have 
students attempt to present differing viewpoints, but in for other topics, students seem able to grasp the 
diverse social impact. 
 
Writing Rubric 
 
 
Grade A B C <C 
Continuity Clear organization 
that walks the 
reader through the 
paper, does not 
stray off central 
theme  
Clear organization 
but strays slightly 
or sections not 
linked  
 
Organization is less 
than clear, or 
organization is clear 
but some digressions 
or poor development 
of a central theme 
Organization is 
lacking and/or 
paper strays 
substantially from 
topic  
 
Support Numerous, varied 
and relevant details 
and facts support 
coherent 
arguments  
Details and facts 
support arguments, 
but may not provide 
enough or may be 
as relevant as 
possible  
Some details and 
facts to support 
arguments, but not 
enough and some 
lack relevancy  
 
Little to no relevant 
details and facts to 
support arguments  
 
Content  
Knowledge 
Demonstrates 
excellent 
understanding of 
content and is 
comfortable with 
nuances in material 
Conveys content 
adequately but fails 
to elaborate  
 
Gets basic content 
correct but is 
otherwise 
uncomfortable with 
material 
 
Basic content is 
wrong, incorrect, or 
substantially 
incomplete  
 
Originality 
 
Demonstrates 
excellent analytical 
originality, either in 
creating new 
arguments or in 
relating facts in 
new ways (beyond 
Demonstrates 
some, but not a 
great deal of, 
analytical 
originality, either in 
creating new 
arguments or in 
Demonstrates little 
analytical originality, 
relies mainly on 
arguments and 
evidence already 
covered in class  
 
Makes no attempt 
to provide original 
analysis  
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what is covered in 
course material)  
relating facts in 
new ways  
Citation Variety of citations 
which support the 
text 
 
Adequate citations, 
but some sense 
that text describes 
the limited number 
of citations found  
Limited variety of 
citations.  Not much 
evidence of 
scholarship  
 
Few citations 
 
Vocabulary Rich and 
appropriate use of 
scientific 
vocabulary 
Generally good 
vocabulary use 
Limited scientific 
vocabulary, not 
always precise or 
accurate  
Incorrect use of 
scientific 
vocabulary, very 
limited range  
Grammar No major errors,  
a few minor errors 
that do not distract  
One major error  
or several minor 
errors that do not 
distract  
Two or three major 
errors combined with 
minor errors 
Numerous major 
errors 
 
Argumentat
ion 
conclusion 
Paper has clear, 
original arguments 
that go beyond 
description  
Paper has 
discernable 
arguments but may 
be somewhat 
unclear or weak  
Paper has arguments 
but often falls into 
description  
 
Paper has little to 
no arguments, 
spends most time 
describing  
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Presentation Evaluation 
Evaluation of Presentation  Presenter’s name_______________________________ 
 
1.  I understood what the presentation was about.       NO 1 2 3 4 5 YES 
2. The flow of the presentation was logical.       NO 1 2 3 4 5 YES 
3. The presenter spoke clearly.         NO 1 2 3 4 5 YES 
4. The slides were clear and easy to understand.     NO 1 2 3 4 5 YES 
5. The presenter spoke to the audience.       NO 1 2 3 4 5 YES 
6. The presenter made good use with the pointer.      NO 1 2 3 4 5 YES 
7. The presentation was within the prescribed time limits (20 min +/- 2 min.). NO 1 2 3 4 5 YES 
8. The presenter answered questions clearly (no B.S.).     NO 1 2 3 4 5 YES 
9. The presenter gave his/her opinion of the state of the science in this subjectNO 1 2 3 4 5 YES 
10. I would enjoy listening to this type of presentation again.     NO 1 2 3 4 5 YES 
 
Score:   _______/50  Your name___________________________________ 
 
 
Appendix II 
30 
Feb. 14, 2014 Exam 1 Name__________________ 
1. (4)  Match the sugar structure with the corresponding name
a. ______Glucose
b. ______Fucose
c. ______Mannose
d. ______Sialic acid
1.    2.    3.     4. 
2. (2)   Explain why glucose forms a red precipitate in Benedict’s solution and sucrose does not.
3. (2)  Why can we eat starches in breads, cereals, etc but not cellulose even though they are
made from the same sugar molecules?
4. (1)   T/F  When two sugars are linked together, a dehydration reaction takes place.
5. (6)   Name the following (sugars + linkage type like we did in class)
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6.  (1)   Which of the following is not true? 
a.  HFCS makes frozen items softer 
b. HFCS increases sweetness intensity 
c. HFCS  increases nutritional value 
d. HFCS is more economical than table sugar 
e. HFCS makes baked goods softer/chewier 
 
7.  (1)  T/F  Glucose and Fructose follow the same metabolic pathways.  (Sugar is sugar, your body 
can’t tell the difference). 
 
8. (2)   What technique is employed to concentrate HFCS in concentrations greater than 42%?   
 
 
 
9. (1)   HFCS from the corn kernel is derived from 
a. Germ 
b. Starch 
c. Gluten 
d. Fiber 
e. All the above 
 
10.  (1)  Corn starch is primarily  
a. polymers of glucose (amylose) 
b.  polymers of fructose 
c.  monomers of glucose and fructose 
d.  cellulose 
e. none of the above 
 
11.  (2)  For the following reaction, draw the Schiff base and Amadori products from the aldehyde 
and amine containing molecules.   
        OH     Schiff base   Amadori 
   R-C-C=O   +    N2H-R’    
       H H  
 
12. (2)   What key enzyme regulates glucose and not fructose from going all the way to acetyl-CoA, 
the precursor for fatty acid synthesis. 
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13.  (2)  Why is glucose phosphorylated when entering the cell? 
 
 
14.  (4)  Match the AGE molecule with its precursors 
 a._______GOLD     1.  Arginine + Lysine 
 b. ______ carboxyethyllysine    2.  2 Lysine + 2 glucose 
 c._______pentosidine     3.  Methylglyoxal + lysine 
 d. ______crossline     4.  Glyoxal + 2 lysines  
 
15.  (1)  Pathological conditions associated with advanced glycation end-products include 
 a.  hardening of the lens of the eye 
 b.  loss of skin elasticity 
 c.  cross-linking of collagen and other protein fibers 
 d.  all the above 
 e.  none of the above 
 
16.  (2)  Fill in the blanks for the polyol pathway 
 
 Glucose   _____________  _______________ 
      Aldose reductase   sorbitol dehydrogenase   
 
17.  (2)  The HbA1c test evaluates the average amount of sugar in the person’s blood.  What is 
measured and why is this test a better measure for diabetes versus taking a fasting blood sugar 
measurement?  
 
 
 
 
 
 
 
18.  (3)  Influenza is a persistent viral disease throughout the world.  The virion attaches to sialic acid 
via a surface receptor called _______________________.  Once inside the cell, it replicates and 
buds from the cell by cleaving (cutting) the sugar _______________________ using the enzyme 
called _________________________. 
 
19.  (2)  With the constant outward flow of membrane material in the Golgi, briefly explain one of 
the three methods employed to retain glycosyltransferases within the Golgi stacks. 
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20.  (1)  When building a structure, the nucleotide sugar in conjugated to an acceptor.  That acceptor 
may be a. 
 a.  lipid 
 b.  sugar 
 c.  protein 
 d.  all the above 
 
21. (2)   What two properties differentiate GT-A and GT-B glycosyltransferases? 
 
 
 
 
 
22.  (2) Explain the function of the isoprenol lipid, Dolichol, in glycosylation. 
 
 
23. (1) Oligosaccharyltransferase (OST) is made up of several subunits and common among all 
eukaryotes.  The subunit that is most evolutionarily conserved and most functional is 
a. Stt3A 
b. Ribophorin II 
c. DAD1 
d. OST4 
 
24.   (2) Which statement is true? 
a. OST recognizes the sequence NXT/S and adds GlcNAc-diphosphate to the asparagine. 
b. OST recognizes the sequence C2X4CTX3C and adds a 14 sugar GlcNAc-Man structure from 
dolichol to the threonine of the protein. 
c. OST recognizes the NXT/S sequence of the growing polypeptide and adds a 14 sugar GlcNAc-
Man structure from dolichol to the asparagine of the protein. 
d. OST recognizes the NXT/S sequence of the growing polypeptide and utilizes a single UDP-
GlcNAc to modify the asparagine of the protein. 
 
25.  (1) GlcNAcTII is responsible for 
a. Adding a single GlcNAc to the polypeptide chain 
b. Branching of the oligosaccharide structure 
c. Trimming of the oligosaccharide structure 
d. Cutting the polypeptide chain 
 
26.  (2) How are insect N-glycans different from human N-glycans? 
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27. (2) What enzyme in the cis-Golgi does the majority of trimming of the mannose sugars from a N-
glycan? 
a. α-1,2 glucanase 
b. Mannosidase II 
c. α-1,2 mannosidase 
d. GlcNAcTIV 
 
28. (2) The addition of a GlcNAc to a Tn antigen forms which structure for the O-glycans? 
a. Core 1          
b. Core 2 
c. Core 3 
d. Core 4 
 
29.  (2) Explain why the mucins are so slimy and gooey. 
 
 
30.  (2) What is the function of ppGalNAcT1? 
 
 
   
31.  (1) (T/F)  High amounts of cervical mucus will increase the chance of conception. 
 
32.  (2) Explain how mucus protects the GI tract (colon, large intestine, and lower small intestine). 
 
 
33.  (2) Give two reasons why proteins are N-glycosylated. 
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March 21, 2013     Exam 2   
 Name________________________ 
 
1. (2 pts)  If A + B         AB and k1= 104 and k2=101, what is KD? 
a.  103 
b. 102 
c. 10-3 
d. 10-2 
e. 10-5 
 
2. (1 pt)  Lectins typically bind with their ligands in the low ____________ range. 
a.  Millimolar 
b. Micromolar 
c. Nanomolar 
d. Picomolar 
 
3.  (2 pts) Ricin is an R-type lectin that is a WMD classified material.  How does it kill the cell (and 
eventually the individual)? 
 
 
4.  (9 pts) Matching. 
a.______Endo 180    1.  Inhibitory receptor for many types of white 
blood cells 
b.______Mannose receptor   2.  Involved with the release of arachidonic acid 
c.______DEC205    3.  Found on endothelial cells 
d.______Phospholipase A2 receptor  4.  Bind to non-sialated ligands in liver 
e.______ASGPR     5.  Scavenger receptor; binds to pituitary 
hormones 
f.______CD33     6.  Inhibitory for B-cell receptors 
g.______Siglec-2    7.  Presents antigens to T-cells 
h.______Gal-1     8.  Binds phospho-GlcNAc in Golgi 
i.______ E-selectin    9.  Assists in remodeling of extracellular matrix 
      10.  Often overexpressed in certain cancers. 
 
5.  (2 pts) P-selectin and PSGL-1 bind with low affinity.  What 2 structures on PSGL-1are required 
for binding when P-selectin contributes a Ca2+? 
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6.  (2 pts) Why is low affinity binding of the selectins advantageous for the white blood cell? 
 
 
7.  (2 pts) Explain the “magic bullet” concept for the treatment of acute myloid leukemia (AML). 
 
8. (4 pts) Match 
a.______ Enzyme that adds a phosphate group   1.  OGA 
b.______ Enzyme that cleaves off O-GlcNAc   2.  Kinase 
c.______ Enzyme that cleaves off a phosphate   3.  OST 
d.______ Enzyme that adds a O-GlcNAc    4.  Phosphatase 
        5.  OGT 
9.  (2 pts) Give 2 reasons for why O-GlcNAcylation of proteins was missed for so long. 
 
 
10.  (2pts) How does O-GlcNAcylation of proteins affect signaling pathways in cells? 
 
 
 
11.  (2 pts) Why has it been difficult to develop anti-inflammatory drugs targeting the selectins? 
 
 
12.  (2 pts) What causes I-cell disease and which lectin is involved? 
 
 
13. (1 pt)  (T/F) ERp57 associated with Calnexin is primarily responsible for forming disulfide bonds. 
 
14.  (5 pts) Matching 
a._____Uncovering enzyme  1.  Directly involved with Pseudo-Hurler Polydystrophy 
b._____α-glucosidase I   2.  Cleaves off the 1st glucose from the N-glycan 
c._____calreticulin   3.  Cleaves off the 2nd glucose from the N-glycan 
d._____GlcNAc Phosphotransferase 4.  Cleaves off GlcNAc and allow M6PR binding 
  Appendix II 
37 
 
e._____α-glucosidase II   5.  Involved with protein folding 
 
15.  (1 pt) The serum of kids with I-cell disease contains high amounts of enzymes from which 
organelle? 
a.  ER 
b. Golgi 
c. Secretory vesicles 
d. Endosomes 
e. Lysosomes 
f. Nucleus 
 
16. (1 pt)  O-fucosylation of EGF domains is mediated by the enzyme 
a. POFUT1 
b. ppGalNAcT1 
c. POGLUT 
d. POMGNT 
e. POMT1 
 
17. (1 pt) What is NOT true about C-mannosylation 
a.  It helps stimulate release of tumor necrosis factor alpha 
b. The motif is W-X-X-W 
c. It does not occur in bacteria 
d. It occurs in the cis-Golgi after the protein is folded 
e. Carbon #1 of the mannose sugar is covalently bonded with tryptophan. 
 
18.  (1 pt) An individual with muscle-eye-brain disease is deficient in which enzyme? 
a. POFUT1 
b. Fringe 
c. POMT2 
d. POMGNT1 
e. Rumi 
 
19.  (1 pt) A lectin is a….. 
a. Carbohydrate that recognizes a specific protein 
b. Protein that recognizes a specific carbohydrate 
c. Protein that recognizes a specific lipid 
d. Lipid that recognizes a specific carbohydrate 
 
20.  (1 pt) What type of sugar moiety is recognized by calnexin and calreticulin? 
a.  High mannose structures containing one glucose 
  Appendix II 
38 
 
b. Non-sialyated galactose or GalNAc structures 
c. Phospho-mannose 
d. Terminal Sialic acids 
e. High mannose structures 
 
21. (2 pt)  In an experiment, you use siRNA to knock-down expression of calreticulin in cultured 
cells.  The next day, you infect the cells with a calicivirus.  You noticed that the viral titer is 
higher than before, but the viruses have very low virulence compared to the original viral stock.  
Why??? 
 
 
 
 
 
 
22.  (5 pt) Matching 
a. _____ Heparin   1.  Composed of repeating sulfated GlcA and GalNAc 
b. _____Heparan sulfate  2.  found in the cornea and essential for corneal clarity 
c. _____Hyaluronic acid  3.  Used as a blood thinner 
d. _____Chondroitin sulfate  4.  Found on virtually all cells 
e. _____Keratan sulfate  5.  Not bound to a core protein 
 
23.  (1 pt) HS and CS core structures are initiated in the ER by an enzyme called_________ which 
recognizes serine 
a.  Xylosyltransferase 
b. Galactosyltransferase I 
c. GalNAc transferase 
d. GlcNAc transferase 
 
24.  (2 pts) What 2 properties make HA synthase so different from the other GAG synthesis 
enzymes? 
 
 
25.  (1 pt) GlcA in heparin is often epimerized to which sugar 
a.  Iduronic acid 
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b. Glucuronic acid 
c. Galacuronic acid 
d. N-acetylglucuronic acid 
 
26.  (2 pts) The addition of heparanase to cells often results in higher levels of growth factors in the 
culture media.  Why? 
 
 
27.  (1 pt) Clearance of large polymers of HA from the blood is mediated by which organ? 
a.  Lymph node 
b. Spleen 
c. Liver 
d. Kidney 
 
28.  (2 pts) What effect does HA have on cancer metastasis and how does size of the HA polymer 
factor in? 
 
 
 
29.  (2 pts) How does HA increase the virulence of Streptococcus? 
 
 
 
30. (1 pt)  (T/F)  HA is often sulfated. 
 
31.  (1 pt) A group of people composed of at least one scientific expert, a lay person, and animal 
care personnel is called the ___________committee. 
a.  IRB 
b. IACUC 
c. AAALAC 
d. Animal Welfare Act  
 
32.  (1 pt) The largest financial provider for biomedical research in the USA is 
a. NSF 
b. NIH 
c. USDA 
  Appendix II 
40 
 
d. DOE 
e. SNAP 
 
Bonus question (3 pts):  Notch undergoes 3 proteolytic events.  Describe where this occurs and 
what enzyme performs each event. 
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January 31, 2014    Quiz 2    Name____________________ 
 
1.  Why was sucrose less reactive than lactose in forming CML? 
a.  It is a disaccharide 
b. It contains fructose 
c. It is a reducing sugar 
d. It is a non-reducing sugar 
 
2.  Tocopherol did not reduce CML formation because  
a.  It is not really an anti-oxidant 
b. It is not water soluble 
c. It is oxidized to erythrose which may induce CML production 
d. None of these 
 
3.  According to this paper, microwave heating created _______________amount of CML than 
conventional heating. 
a.  >4-fold greater 
b. <4-fold lesser 
c. About the same 
d. They could not tell from the data 
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February 5, 2014    Quiz 3   Name___________________ 
 
1.  Treatment of cells in culture with siRNA___________________ expression of a specific gene. 
a.  Decreases 
b. Increases 
c. Does not change 
2.  Cytokines such as IL-6 _________________ expression of C1GalT1 and _________________ 
expression of ST6GalNAc2 in IgA nephropathy patients. 
a.  Increase::decrease 
b. Decrease::increase 
c. Increase::increase 
d. Decrease::decrease 
3.  In which organ were immune complexes most harmful? 
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February 10, 2014   Quiz 4    Name____________________ 
 
1.  Free oligosaccharides produced by OST are formed in which organelle? 
a.  Golgi 
b. ER 
c. Lysosome (vacuole in yeast) 
d. Secretory vesicles 
2.  Which catalytic and conserved subunit(s) is necessary for OST function? 
a.  OST4 
b. DAD1 
c. OST6 
d. Stt3 
e. All the above 
3.  Yeast is a good living model system because 
a.  It is genetically amenable 
b. Of the short generation time between mother and daughter cells 
c. It is cheap to grow up and maintain 
d. Enough cells are produced to perform a wide array of experiments 
e. All the above 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Appendix II 
44 
 
Feb. 21, 2014    Quiz 5    Name___________________ 
 
1.  XXYLT1 was discovered by which method 
a.  Mutagenesis in bacteria 
b. Mutant screening in fruitflies using a temperature sensitive allele 
c. Using GXYLT1 in a position specific iterated (PSI) BLAST search 
d. Creating a cDNA library and probing with a DNA oligo targeted to a consensus sequence. 
 
2.  According to this graph, what is the dominant substrate for XXYLT1? 
 
Answer:________________________ 
 
3.  If you had a synthetic peptide contain a properly folded EGF domain containing the appropriate 
consensus sequence for O-glucosylation and subjected it to a series of reactions in the order of 
(1) Rumi, (2) GXYLT1, and then (3) XXYLT1 each with the proper amount of UDP-sugars, your 
final product would be a sugar modification on the peptide that would look like: 
a. Ser-Xyl-Glc-Xyl 
b. Ser-Glc-Xyl-Xyl 
c. Ser-Xyl-Xyl-Glc 
d. Ser-Glc-Xyl 
Ser = the amino acid, Serine 
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Feb. 26, 2014    Quiz 6    Name____________________ 
1.  (T/F)  Increased phosphorylation of Tau results in a greater potential to develop Alzheimer’s 
disease. 
 
2.  Animals were treated with ThiametG which resulted in the data below.  Indicate the answer 
that best explains this data.  Note:  Otau400 is a monoclonal antibody specific to O-
GlcNAcylation of Tau at Ser400 and HT7 is a pan-specific Tau antibody. 
 
a.  The treatment decreased phosphorylation at site S400 
b. The treatment increased O-GlcNAcylation at site S400 
c. The treatment increased phosphorylation at site S400 
d. The treatment decreased O-GlcNAcylation at site S400 
e. A and B 
f. C and D 
g. Cannot be determined 
 
3.  The animal models used for the experiments in this paper were 
a.  Drosophila 
b.  mice 
c.  rats 
d.  rabbit 
e.  no animal model, used human samples from normal and AD patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Appendix II 
46 
 
 
March 3, 2014    Quiz 7    Name_____________________ 
 
1.  In the experiments outlined in Ramani et al., the use of heparanase III 
a. Promoted shedding of Syndecan-1 
b. Inhibited shedding of Syndecan-1 
c. Made no difference in shedding rates 
 
2.  The conclusion from the adjascent figure is: 
a. Heparanase III is the cause of Syndecan-1 shedding 
b. Heparan sulfate addition causes Syndecan-1 shedding 
c. Heparin addition causes Syndecan-1 shedding 
d. MMPs cause Syndecan-1 shedding 
 
3.  (T/F)  Heparanase and MMP-9 have increased expression 
in cancer, inflammation and wound healing. 
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March 7, 2014    Quiz 8   Name_________________________ 
 
1.  According to Ghatak et al., tumor-stroma interactions required which molecules 
a. HA 
b. HGF 
c. CD44v9 
d. C-Met 
e. PI3K 
f. A and C 
g. All the above 
 
2.  To test metastatic potential, cells are incubated in matrigel and the numbers of cells that 
migrate to the underside are quantified.  In the figure 
below, C4-2 cells were co-cultured with PCMF cells and 
were treated with IgG or anti-HGF antibodies (lanes 1 
and 3) or scrambled shRNA and CD44v9shRNA (lanes 2 
and 4).  What does this tell you about HFG and CD44v9 
a.  HGF and CD44v9 promote invasion 
b. HGF and CD44v9 inhibit invasion 
c. CD44v9 only promotes invasion 
d. HGF only promotes invasion 
e. IgG and control shRNA promote invasion 
 
3.  T/F  CD44-HA interactions seldom occur in most metastatic cancers. 
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March 10, 2014     Quiz 9   Name____________________ 
1.  Pompe disease is 
a. An ER storage disease in which proteins are misfolded and accumulate in the tissues 
b. A lysosomal storage disease in which excess glycogen accumulates in muscle 
c. A Golgi storage disease in which N- and O-glycans accumulate within the cell. 
d. A lysosomal storage disease in which internalized endosomes cannot fuse with the 
lysosome. 
e. Pertinent to only those who live near Mt. Vesuvius in Italy. 
2. Interpret the following experiment.  L6 Myoblast cells were plated in culture well dishes and 
allowed to internalize 3 different preparations of acid a-glucosidase (BMN  701, alglucosidase 
alfa, and rhGAA).  The kuptake for these different GAAs were 5.4, 141, and 147 nM.  Which GAA 
had the uptake of 147 nM? 
 
 
 
 
 
 
 
 
 
 
 
a.  BMN 701 
b. Alglucosidase alfa 
c. rhGAA 
3.  The overall goal of the research in this paper was to 
a.  Target acid α-glucosidase to CI-MPR more efficiently 
b. Produce more acid α-glucosidase within the cell 
c. To get cells to store more glycogen 
d. Show how purified acid α-glucosidase works better than current GAA preparations. 
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March 19, 2014  Quiz 10 Name______________ 
1. PSGL-1 is a ligand for ______________ and expressed on activated _________________
a. E-Selectin::myofibroblasts
b. P-Selectin::Leukocytes
c. L-Selectin::macrophages
d. E-Selectin::Leukocytes
e. P-Selectin::CHO cells
2. Knocking out the cytoplasmic domain (∆CD) of PSGL-1 resulted in
a. Increased expression of PSGL-1
b. Decreased expression of the mutant PSGL-1
c. Increased accumulation of the PSGL-1 precursor
d. Increased accumulation of the PSGL-1 mature isoform
e. A and C
f. B and C
g. B and D
3. T/F  The authors discovered that dimerization of PSGL-1 was required for the receptor(s) to exit
the ER.
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Bittersweet Roles of O-Linked N-Acetylglucosamine in Human Health and Disease 
Department of Biochemistry, University of Nebraska-Lincoln 
Key words: O-linked-N-acetylglucosamine transferase, O-linked-N-acetylglucosamine 
hydrolase, UDP-N-acetylglucosamine, type II diabetes, cancer, Alzheimer’s disease 
Abstract 
Posttranslational modification of nuclear and cytosolic proteins by the addition of O-
linked N-acetylglucosamine (O-GlcNAc) is a dynamic process that is regulated by the 
key enzymes O-GlcNAc transferase (OGT) and O-GlcNAc hydrolase (OGA).  The 
substrate for OGT, UDP-GlcNAc, is the final product of the hexosamine biosynthetic 
pathway.  UDP-GlcNAc is abundant in the cytosol and acts as a metabolic sensor, 
reflecting the overall nutrient levels in the cell.  OGT covalently modifies serine and 
threonine residues by attaching a single O-GlcNAc moiety, which can be cycled on and 
off by coordinate regulation with OGA.  The substrate specificity of OGT is not well 
understood, the modification occurs on a myriad of proteins with no apparent consensus 
sequence.   Importantly, O-GlcNAcylation closely resembles protein phosphorylation 
and the two processes are thought to be coordinately regulated in proteins such as p53 
and tau, which are known to be implicated in cancer and Alzheimer’s disease, 
respectively.   
Over the past 30 years since O-GlcNAcylation was first discovered by Dr. Gerald Hart 
and co-workers, this modification has been found on thousands of proteins and is 
associated with critical cellular functions such as facilitating protein-protein interactions, 
regulating transcription factors, and modulating protein stability.  O-GlcNAcylation has 
proven challenging to study due to its dynamic nature and complex involvement in 
diseases associated with chronic metabolic disregulation.  This review begins with a 
detailed look at the enzymes OGT and OGA, and then outlines recent evidence that O-
GlcNAcylation plays a role in the development and progression of three major human 
diseases: type II diabetes, cancer, and Alzheimer’s disease.  
Introduction 
Posttranslational modification of serine and threonine residues with a single β-C2 O-
linked N-acetylglucosamine (O-GlcNAcylation) is common in nuclear, cytosolic, and 
mitochondrial proteins.  O-GlcNAcylation has been reported in all multicellular 
organisms studied including plants and fungi (reviewed in 1).  O-GlcNAcylation was also 
found in protozoa and a limited number of bacteria (2,3).  This reversible covalent 
modification of proteins is driven by nutrient and hormonal cues and is known to be 
important in regulating metabolic homeostasis.   
Unlike protein phosphorylation, which is regulated by an enormous variety of kinases 
and phosphatases, there are only two enzymes involved in O-GlcNAcylation.  O-GlcNAc 
transferase (OGT) transfers the UDP-GlcNAc onto an acceptor protein and O-
GlcNAcase (OGA) hydrolyzes the sugar from the serine or threonine residue.  Knocking 
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out the OGT gene in mice is embryonic lethal, demonstrating its critical role in 
development and cellular signaling (4).  There is no known consensus sequence for the 
polypeptides that are modified by OGT; however, there is a small group of O-
GlcNAcylated proteins that share the sequence motif PV(S/T) (5).  The extent of protein 
O-GlcNAcylation is dependent upon the concentration of substrate, UDP-GlcNAc, which 
is the final product of the hexosamine biosynthesis pathway.  
O-GlcNAc modification of proteins acts as a metabolic rheostat within the cell due to its 
ability to sense and respond to altered nutrient levels through O-GlcNAc-mediated 
signaling.  O-GlcNAcylation has been shown to severely alter the function of many 
important proteins by influencing substrate affinity, stability, and intracellular localization 
(6).  Aberrant O-GlcNAcylation is associated with human metabolic diseases including 
diabetes mellitus type 2, cancer, and neurodegenerative diseases such as Alzheimer’s 
disease.   
Hyperglycemia increases intracellular levels of UDP-GlcNAc, leading to hyper-O-
GlcNAcylation of proteins, including those involved in insulin signaling.  In type II 
diabetes, O-GlcNAcylation of insulin related proteins results in decreased efficiency of 
insulin-mediated signal transduction (7).  Cancer associated changes in O-
GlcNAcylation are complex and appear to be unique to each different type of cancer.  In 
general, O-GlcNAc cycling promotes metastasis and cancer progression through the 
dynamic modification of several proteins.  In prostate cancer, for example, O-
GlcNAcylation of the oncogenic transcription factor FoxM1 leads to increased 
expression of matrix metalloproteinases which are involved in remodeling of the 
extracellular matrix, allowing for higher metastatic potential (8).  Lastly, alteration of O-
GlcNAc modification is strongly implicated in neurodegenerative diseases including 
Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.  Cytoskeletal 
proteins such as tau have been shown to be O-GlcNAcylated, which prevents 
hyperphosphorylation leading to protein aggregation and improves prognosis for 
neurodegenerative diseases in mice models (9).  Overall, it is clear that O-linked N-
acetylglucosamine modification plays a complex and significant role in human health 
and disease.  
Enzymes Involved in O-linked N-acetylglucosamine Cycling 
O-GlcNAc transferase (OGT) is a cytosolic glycosyltransferase that uses α-linked 
uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) as a substrate to transfer O-
GlcNAc onto a serine or threonine residue through a β-glycosidic linkage (with inversion 
of anomeric configuration).  UDP-GlcNAc is the final product of the hexosamine 
biosynthesis pathway and is considered to be a sensor for the metabolic state of the 
cell.  UDP-GlcNAc biosynthesis integrates nucleotide, nitrogen, glucose, and fatty acid 
metabolism, and is reflective of the overall energy state of the cell.  In most cells, UDP-
GlcNAc is the second most abundant energy-containing metabolite present, second 
only to ATP.   
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Figure 1. Three isoforms of OGT have different lengths of N-terminal 
tetratricopeptide repeats (TPR), shown in orange. The two glycosyltransferase 
catalytic domains are shown in blue and light blue and the hinge-like region is 
shown in green. This figure was taken from reference 46.  
 
There are three different splice variants of human OGT, each with a different number of 
N-terminal 34 amino acid tetratricopeptide repeats (TPR).  The full-length enzyme 
(ncOGT) is 110 kDa with 11.5 TPR repeats, followed by 103 kDa (mOGT) and 78 kDa 
(sOGT) (10).  The full-length enzyme adds O-GlcNAc to cytosolic and nuclear proteins, 
while mOGT primarily modifies mitochondrial proteins.  The crystal structure of human 
OGT (hOGT) was solved in 2004 by Jinek et al. (11).  The structure showed that the 
TPR repeats form elongated superhelices, which are thought to facilitate protein-protein 
interactions.  These interactions are important in recruiting substrate proteins to the 
OGT active site to be O-GlcNAcylated.  The bacterial homolog was crystallized in 2008, 
leading to the identification of the active site of OGT (12).  The active site is split into 
two different domains, with an intervening hinge-like region, which facilitates the release 
of the O-GlcNAcylated peptide (as seen in Figure 1).  A third crystal structure, hOGT 
bound with UDP and a peptide substrate, was key in discovering the location of peptide 
substrates in the active site of OGT (13).  From this structure, they found that the UDP-
GlcNAc must bind first, before the polypeptide substrate, which binds on top and blocks 
access to the nucleotide-sugar binding pocket.   
 
Mechanistically, it is unclear which residue in the active site is serving as the general 
base required for OGT catalytic activity.  Furthermore, there is no definitive consensus 
sequence for the peptide substrates, although it has been suggested that there is some 
preference for peptides with side chains on both sides of the O-GlcNAcylated serine or 
threonine (14).  Identifying which protein motifs act as O-GlcNAc acceptors would help 
predict which proteins are targeted by O-GlcNAcylation.  Bioinformatics tools have been 
developed to assist in predicting which proteins may be O-GlcNAcylated, including two 
programs that use support vector machine algorithms, OGlcNAc Scan and O-GlcNAc 
PRED, and one that uses a artificial neuronal network algothrim, YinOYang (15).     
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Figure 1. OGT catalyzes the addition of O-GlcNAc to serine and threonine 
residues, while OGA acts as a hydrolase, releasing the O-GlcNAc moiety from 
the protein.  The intracellular UDP-GlcNAc pool reflects the nutrient status of the 
cell through the hexosamine biosynthetic pathway (HBSP). This figure was taken 
from reference 46. 
 
The complex regulatory mechanisms of OGT are not fully understood.  Previous studies 
suggest that regulation occurs primarily at the level of post-translational modification of 
OGT due to the sensitivity of O-GlcNAc levels in response to the cellular environment 
(16).  Protein-protein interactions are also a likely component of OGT regulation, as 
some proteins have been shown to alter the activity of OGT, preventing O-GlcNAc 
transfer to specific residues (17). 
 
O-GlcNAc hydrolase (OGA) was initially thought to be a hyaluronidase, though was later 
found to be a two domain protein that catalyzes the hydrolysis of O-GlcNAc from serine 
and threonine residues with retention of anomeric configuration.  There are two splice 
variants of human OGA (hOGA), the full length OGA-L is cytosolic, while the truncated 
OGA-S lacks the C-terminal histone acetyltransferase (HAT) domain and localizes to 
the nucleus (18).  HAT domains catalyze the acetylation of lysine residues on histones, 
which is generally linked to increased transcriptional activity.  OGA-S has been shown 
to associate with different protein-protein interacting partners than OGA-L, but it retains 
hydrolytic activity upon deletion of the HAT domain(19).  There are currently no crystal 
structures of hOGA available, but the structures of two bacterial homologs have been 
solved.  Some evidence suggests that there are surface residues important in recruiting 
hOGA to O-GlcNAc modified proteins (20). Enzymatically, OGA uses a two-step 
catalytic mechanism with the formation of an oxazoline intermediate (21).   
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The structural and mechanistic details of the two enzymes involved in O-GlcNAc 
cycling, OGT and OGA, have shed light on the importance of O-GlcNAc modification in 
human health and disease.  One salient question that remains is how are OGT and 
OGA able to coordinately regulate the addition and removal of O-GlcNAc from hundreds 
of different peptides?  As mentioned previously, post-translational modification of OGT 
and OGA is a likely mechanism for controlling both enzyme activity and protein-protein 
interaction partners.  In addition, the various OGT and OGA isoforms have different 
catalytic efficiencies, and thus, impact overall regulation of O-GlcNAcylation.   
 
O-GlcNAcylation in Type II Diabetes 
 
Type II diabetes mellitus is a chronic metabolic disorder in which cells are unable to 
respond to normal levels of insulin, a peptide hormone responsible for suppressing 
glucose release in the liver when there is an excess of nutrients present.  This results in 
hyperglycemia and retention of water and salt by the kidneys.  Furthermore, insulin 
resistance leads to metabolic disregulation and alters the flux through the hexosamine 
biosynthetic pathway.  Surprisingly, combining the results of several studies suggests 
that both nutrient excess and nutrient limiting conditions may cause a global increase in 
O-GlcNAcylation levels in cells and tissues such as erythrocytes, leukocytes, liver, and 
heart (22).  Thus, O-GlcNAcylation may be a means of responding to the highly 
dynamic metabolic status of the cell, with a certain threshold level of O-GlcNAcylation 
required for proper signaling to occur.   
 
In a hyperglycemic state associated with type II diabetes, high glucose levels promote 
increased flux through the hexosamine biosynthetic pathway leading to an elevated 
intracellular concentration of UDP-GlcNAc (23).  Experimentally, elevation of UDP-
GlcNAc levels by glucosamine treatment or inhibition of OGA using O-(2-acetamido-2-
deoxy-D-glucopyranosylidene) amino-N-phenyl-carbamate (PUGNAc) causes insulin 
resistance in 3T3-L1 adipocytes (24).  Conversely, inhibition of OGA with a more 
selective OGA inhibitor, Thiamet G, does not result in insulin resistance in 3T3-L1 
adipocytes (25).  Overexpression of OGT in fat and muscle tissues results in mice with 
an insulin resistant phenotype, while OGA overexpression increases glucose tolerance 
and insulin sensitivity in insulin-resistant diabetic mice fed a high-fat diet (26, 27).  In 
addition, it has been shown that single nucleotide polymorphisms in the OGA gene 
MGEA5 is associated with a significantly higher rate of developing diabetes (28).  
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Figure 3: Insulin binds to a tyrosine kinase receptor on the cell surface activating intracellular 
signaling pathways that increase glucose uptake and metabolism. Increased flux through the 
hexosamine biosynthetic pathway (HBP) increases the intracellular UDP-GlcNAc pool stimulating 
transcription of gluconeogenic and lipogenic genes.  Overall, O-GlcNAcylation of several proteins 
involved in signaling and transcriptional regulation leads to attenuation of insulin signaling (light 
green circle denotes O-GlcNAc). This figure was taken from reference 47.  
 
 
Increased UDP-GlcNAc levels promote O-GlcNAcylation of transcription factors such as 
NeuroD1, PDX-1, and MAF-1 which are directly involved in regulating insulin 
transcription by pancreatic β cells (29, 30).  Furthermore, O-GlcNAcylation competes 
with phosphorylation of Insulin Receptor Substrate 1 (IRS1) at tyrosine 608, leading to 
inhibition of AKT activation and, as a result, a decrease in glucose uptake through the 
glucose transporter type 4 (GLUT4) (31).  Finally, various co-activators and transcription 
factors associated with gluconeogenesis such as peroxisome proliferator-activated 
receptor gamma coactivator 1-α (PGC-1α), transducer of regulated cyclic adenosine 
monophosphate response element binding protein 2 (CRTC2), and forkhead box protein 
1 (FoxO1), have all been shown to be O-GlcNAcylated, contributing to the regulation of 
nuclear localization and transcriptional activation of these proteins and promoting 
glucose toxicity under insulin resistant conditions (32, 27, 33).  Thus, O-GlcNAcylation 
of proteins associated with insulin signaling, glucose uptake, and gluconeogenesis 
provides molecular mechanisms of metabolic regulation linked to the nutrient status of 
the cell.   
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Another protein associated with type II diabetes that has shown to be O-GlcNAcylated is 
endothelial nitric oxide synthase (eNOS).  eNOS plays a role in regulating vascular 
resistance through the production of nitric oxide.  O-GlcNAcylation of eNOS prevents its 
phosphorylation, leading to decreased nitric oxide production and endothelial cells with 
vascular abnormalities (34).  Chronic inhibition of eNOS activity through O-
GlcNAcylation may contribute to the association between accelerated atherosclerosis 
and type II diabetes.   
 
While O-GlcNAcylation of key proteins plays a role in regulating signaling cascades 
associated with normal metabolic homeostasis, prolonged O-GlcNAcylation as a result 
of excess caloric intake or starvation may cause the effects to transition from protective 
to deleterious, as seen in type II diabetes.  Therefore, understanding the molecular 
mechanisms of O-GlcNAc cycling has the potential to provide new therapeutic targets 
for treating type II diabetes.  Furthermore, O-GlcNAcylation seems to be an important 
link between type II diabetes and other diseases associated with altered glucose 
metabolism, such as cancer.  
 
O-GlcNAcylation in Cancer  
 
Alteration of cellular metabolism is one of the hallmarks of cancer.  Cancer cells require 
unusually high amounts of glucose in order to provide energy and building blocks for 
lipids, proteins, and nucleic acids, which are in high demand in rapidly proliferating cells.  
Glucose and glucosamine are the preferred sources of energy and biosynthetic 
precursors in cancer cells.  As the major fuel sources, glucose and glucosamine also 
drive flux through the hexosamine biosynthetic pathway, resulting in a myriad of O-
GlcNAcylated proteins, which play key roles in regulating the molecular mechanisms of 
cancer.  
 
Increased O-GlcNAcylation of proteins and altered OGT and OGA expression have 
been associated with different types of cancer including: breast, liver, colon, lung, 
bladder, endometrial, prostate, and chronic lymphocytic leukemia cells (35).  Although 
each type of cancer should be considered independently, in general, cancer is most 
commonly associated with increased O-GlcNAcylation along with elevated expression 
levels of OGT.  There is no apparent cancer-associated pattern of expression for OGA.  
O-GlcNAcylation of a wide range of proteins is associated with many essential 
processes in cancer cell survival, proliferation, and metastasis such as: mitogenic 
signaling, cell cycle regulation, transcription factor activation, and cell adhesion and 
migration.         
 
Modification of proteins by O-GlcNAcylation regulates cell cycle progression at each of 
the critical checkpoints.  Most cells are in the G0 or quiescent state, and entry into the 
G1 stage of the cell cycle requires activation of the MAP kinase and PI3K pathways by 
exogenous mitogenic signals.  This leads to transcription of cyclin D1, the key 
regulatory protein of the G1 phase.  Blocking OGT activity has been shown to delay 
production of cyclin D1, preventing entrance of quiescent cells into the G1 phase and, 
therefore, inhibiting proliferation (36).  Furthermore, inhibition of OGA accelerates 
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proliferation rates, while decreasing flux through the hexosamine biosynthesis pathway 
corresponds to decreased cellular proliferation.  This trend of increased O-
GlcNAcylation promoting cell cycle progression continues at every stage except for the 
G1/S checkpoint, where there is a global decrease in O-GlcNAcylated proteins (37).  
 
Mutations in transcription factors leading to disregulation of gene expression is common 
in cancer.  Posttranslational modifications are also responsible for regulation of 
transcription factor activity.  Several cancer related transcription factors have been 
shown to be modified by O-GlcNAcylation including: MYC, FOXM1, p53, NF-κB, and β-
catenin (35).  The protein MYC is an oncogenic transcription factor often overexpressed 
in cancer.  MYC is typically degraded upon phosphorylation of threonine 58, though 
extensive O-GlcNAcylation of MYC blocks phosphorylation at position 58 and stabilizes 
MYC, promoting proliferation (38).   FOXM1 regulates transcription and is found to be 
associated with tumorigenesis.  Although FOXM1 has not been shown to be directly 
modified by O-GlcNAcylation, OGT inhibition led to dramatically reduced levels of 
FOXM1 in breast cancer MCF-10A cells (39).  The tumor suppressor protein p53 is 
highly implicated in cancer progression.  Phosphorylation of p53 at threonine 155 
targets it for proteosomal degradation when there are no signs of cellular stress.  O-
GlcNAcylation of p53 at serine 149 has been shown to inhibit phosphorylation at residue 
155, stabilizing p53 and allowing it to act as a transcription factor involved in triggering 
cell cycle arrest and apoptosis (40).  Therefore, O-GlcNAcylation of p53 often signals 
cellular stress and is essential in preventing the cell from further propagation under such 
conditions. β-catenin is a transcription factor that is involved in regulating proliferation 
and cell cycle progression.  Mutations in β-catenin which increase its stability are 
oncogenic and are commonly found in colorectal cancer.  Studies in colonic carcinoma 
cells show that increased flux through the hexosamine biosynthetic pathway is 
correlated with elevated β-catenin expression levels and an increase in global O-
GlcNAcylation (41).  Although O-GlcNAcylation of oncogenic and protooncogenic 
transcription factors is highly dependent on each individual type of cancer, this dynamic 
posttranslational modification appears to be an important factor linking metabolic status 
with control of crucial cellular processes such as transcriptional regulation, cell cycle 
progression, and proliferation.  
 
O-GlcNAcylation can also impact cellular adhesion and migration leading to increased 
metastatic potential of cancer cells.  E-cadherin is a transmembrane protein involved in 
cell-cell adhesion.  Downregulation of E-cadherin is associated with epithelial-
mesenchymal transition (EMT), which is characteristic of invasion of the basement 
membrane by carcinoma and subsequent translocation and colonization of a secondary 
tumor site, otherwise known as metastasis.  O-GlcNAcylation has been demonstrated to 
regulate expression of E-cadherin, thus influencing cancer invasiveness in breast 
cancer (42).  The transcription factor Snail1 mediates EMT by repressing E-cadherin 
expression and was found to be stabilized by O-GlcNAcylation in ovarian cancer cell 
lines in the presence of OGT and hyperglycemic conditions (43).  Lastly, matrix 
metalloproteases (MMPs) are enzymes involved in extracellular matrix remodeling, and 
thus provide conditions that support invasion of basement membrane by carcinoma.  
The proteolytic activity of MMPs is required for intravasation of cancerous cells from the 
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tissue, through the basement membrane, and into the blood vessels, where the 
cancerous cell circulates until it undergoes extravasation into the tissue at a secondary 
location.  Reduced O-GlcNAcylation in prostate cancer causes decreased expression of 
MMP2 and MMP9 as well as a decrease in FOXM1 expression (8).  The same study 
showed that blocking OGT led to decreased metastasis of tumors in vivo.  Overall, it is 
clear that O-GlcNAcylation is involved in regulating EMT and MMPs, both of which are 
critical in extracellular matrix remodeling, a key determinant of the invasiveness and 
metastatic potential of cancer cells.  
 
O-GlcNAcylation in Alzheimer’s Disease 
 
Improper glucose metabolism is linked to neurodegenerative diseases such as 
Alzheimer’s disease.  There is significant evidence that O-GlcNAcylation is also 
implicated in Parkinson’s disease and Huntington’s disease, but in this review I will 
focus on Alzheimer’s disease.  Studies continue to provide evidence of an increasingly 
strong correlation between insulin resistance, obesity, and Alzheimer’s disease.  This 
may suggest that incessant exposure to extreme imbalance of nutrients is a risk factor 
for developing certain neurodegenerative diseases linked to chronic metabolic 
disregulation.  It has been hypothesized that inefficient glucose utilization in the brain 
leads to lower cytosolic levels of UDP-GlcNAc, thus causing an overall decrease in O-
GlcNAcylation of proteins in the brain.    
   
Alzheimer’s disease is a neurodegenerative disease characterized by accumulation of 
neurofibrillary tangles, which are composed of microtubule-associated tau protein 
monomers that assemble into paired helical filaments.  The progression of the disease 
is characterized by the buildup of these neurofibrillary tangles.  It is not well understood 
which factors contribute to the aggregation of tau monomers on the molecular level, 
although it is expected to be driven by a conformational change in the tau monomer.  
One widely accepted example of this is hyperphosphorylation of tau leading to 
increased formation of neurofibrillary tangles; however, it is estimated that there are 
other posttranslational modifications that may also elicit conformational changes 
resulting in aggregation of tau proteins.  One such modification is O-GlcNAcylation.  
 
Experimental evidence shows that O-GlcNAcylation of tau occurs in a manner 
reciprocal to phosphorylation, and that neurofibrillary tangles consist of tau monomers 
that are phosphorylated, but not O-GlcNAcylated (44).  This seems to support the role 
of O-GlcNAcylation in preventing tau aggregation by competing with phosphorylation for 
modification of serine and threonine residues.  Treatment with the OGA inhibitor 
Thiamet G reduces tau phosphorylation and prevents neurodegeneration related to tau 
aggregation in mouse models (9).  Complimentary studies have found that O-
GlcNAcylation of human tau impairs the extent and overall rate of aggregation without 
perturbing its global conformational properties or activity related to microtubule 
polymerization (45).  Thus, O-GlcNAcylation of tau clearly plays a role in preventing its 
phosphorylation and subsequent formation of neurofibrillary tangles, however, the 
change in conformation of tau may be more subtle than previously anticipated.  O-
GlcNAcylation of tau provides an important link between altered glucose metabolism 
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and posttranslational modification of tau involved in neurodegeneration.  Furthermore, 
O-GlcNAcylation decreases with age as the brain becomes less efficient in processing 
sugars, and the number one risk factor of developing Alzheimer’s disease is aging, 
followed by obesity and diabetes.   
 
Conclusions and Future Directions  
 
Covalent modification of proteins with O-linked N-acetylglucosamine is a dynamic, 
nontemplated process that serves a role in cellular signaling and reflects the metabolic 
status of the cell based on the concentration of UDP-GlcNAc in the cytosol.  O-
GlcNAcylation is predicted to target over 4,000 different proteins and has been shown to 
have profound impacts, ranging from activation of key transcription factors to altering 
protein stability to mediating protein-protein interactions.  Efforts to elucidate the 
molecular mechanisms of the critical enzymes OGT and OGA have facilitated 
considerable progress in understanding O-GlcNAcylation and its regulation.  
Importantly, O-GlcNAc modification plays a critical role in several diseases, including 
type II diabetes, cancer, and Alzheimer’s disease.       
 
Detection methods continue to improve with the help of chemical biology techniques, 
allowing for increasingly dynamic monitoring of O-GlcNAc cycling under various cellular 
conditions.  In the future, it will be important to characterize O-GlcNAcylation across the 
entire proteome in order to comprehensively understand the impact of metabolic 
disregulation on protein O-GlcNAcylation.  Once the regulation of O-GlcNAcylation is 
more broadly understood for various tissues and disease states, we can begin to 
therapeutically target the associated enzymes, OGT and OGA.  As discussed earlier, 
several inhibitors have already been characterized for both OGT and OGA, although at 
this point it is too early to tell if their mechanism of action is precise enough to target 
associated diseases.  Moreover, there are several new areas of O-GlcNAcylation 
research that were not addressed earlier in this review, but have significant potential to 
impact the field, including the roles of O-GlcNAcylation in epigenetic regulation and 
stem cell biology.  
 
Epigenetic modifications such as histone acetylation, methylation, phosphorylation, and 
many others play an important role in integrating intracellular signaling pathways with 
regulation of gene expression.  In particular, acetylation of histones by HAT is 
associated with increased transcriptional activity.  As noted previously, OGA contains a 
HAT domain, which suggests that O-GlcNAcylation is coordinately regulated with 
histone acetylation.  Several independent studies have shown that histones can be O-
GlcNAcylated; for example, in HeLa cells, it was found that histones H2A, H2B, and H4 
are dynamically O-GlcNAcylated in response to the cell cycle and cellular stress (48). 
Other studies discovered that O-GlcNAcylation of H2B at serine 112 depends on the 
glucose levels in the cell and O-GlcNAcylation promotes monoubitquination of the 
adjacent lysine 120, important in transcription activation (49).  Lastly, OGT has been 
shown to associate with ten-eleven translocation proteins (TETs), which demethylate 
DNA, further extending the evidence for coordinate regulation by methylation, 
acetylation, ubiquination, phosphorylation, and now O-GlcNAcylation (50).   
Sample of an excellent review paper  Appendix III 
60  
 
Although O-GlcNAc signaling is implicated in diverse cellular processes including 
embryonic development, it is not known what role O-GlcNAc plays in embryonic stem 
cells (ESC) and pluripotency.  Recent studies have investigated the role of O-
GlcNAcylation in the regulatory network of pluripotency factors.  The key transcription 
factors involved in regulating stem cell pluripotency are OCT4, SOX2, and NANOG 
(reviewed in 51).  Youn and co-workers found that blocking O-GlcNAcylation disrupts 
the self-renewal of ESC and reprogramming of somatic cells to induced pluripotent stem 
cells (iPSCs) (52).  In their study, they found that core pluripotency factors, OCT4 and 
SOX2, are O-GlcNAcylated in ESC, but the sugar is rapidly removed following 
differentiation.  Blocking the O-GlcNAcylation of OCT4 by modifying a critical threonine 
residue at position 228 reduced the capacity for self-renewal in ESC and limited the 
reprogramming of somatic stem cells into iPSCs.  In addition, there is evidence that in 
mice ESC, there are over 60 nuclear proteins that are O-GlcNAcylated, many of which 
are critical for maintaining ESC (53).  Polycomb repressive complexes (PRC) are an 
assembly of proteins which are necessary for developmentally regulated transcriptional 
silencing of genes which are crucial for embryonic patterning (54).  It was found that 
PRC2 is required in murine ESCs in order to maintain O-GlcNAcylation (53).  Thus, 
OGT is considered a polycomb-group gene, emphasizing its importance in embryonic 
development and stem cell regulation.  
 
References 
1.  Olszewski, NE, West, CM, Sassi, SO, and Hartweck, LM. 2010. O-GlcNAc protein 
modification in plants: Evolution and function. Biochim. Biophys. Acta. 1800:49-56. 
2.  Dieckmann-Schuppert A, Bause E, Schwarz RT. 1993. Studies on O-glycans of 
Plasmodium-falciparum-infected human erythrocytes. Evidence for O-GlcNAc and 
O-GlcNAc-transferase in malaria parasites. Eur. J. Biochem. 216:779-788. 
3.  Shen, A, Kamp HD, Grundling, A, and Higgins, DE. 2006. A bifunctional O-GlcNAc 
transferase governs flagellar motility through anti-repression. Genes Dev. 20:3283-
3295. 
4. Shafi, R, Iyer, SP, Ellies LG, et al. 2000. The O-GlcNAc Transferase Gene Resides 
on the X Chromosome and is Essential for Embryonic Stem Cell Viability and Mouse 
Ontogeny. Proc Natl Acad Sci USA, 97:5737-9.  
5.  Vosseller, K, Trinidad JC, Chalkley RJ, et al. 2006. O-linked N-acetylglucosamine 
Proteomics of Postsynaptic Density Preparations Using Lectin Weak Affinity 
Chromatography and Mass Spectrometry. Mol. Cell Proteomics. 5:923-34.  
6.  Bond, MR, and Hanover, JA. 2013. O-GlcNAc Cycling: A Link Between Metabolism 
and Chronic Disease. Annu. Rev. Nutr. 33:205-29. 
7.  Forsythe ME, Love DC, Lazarus BD, et al. 2006. Caenorhabditis elegans Ortholog of 
 a Diabetes Susceptibility Locus: oga-1 (O-GlcNAcase) Knockout Impacts O-GlcNAc 
Cycling, Metabolism, and Dauer. Proc. Natl. Acad. Sci. USA.103:11952–57. 
8.  Lynch, TP, Ferrer, CM, Jackson, SR, et al. 2012. Critical Role of O-linked β-N-
acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and 
Metastasis. J. Biol. Chem. 287:11070-81.  
9.  Yuzwa SA, Shan X, Macauley MS, et al. 2012. Increasing O-GlcNAc Slows 
Sample of an excellent review paper  Appendix III 
61  
 Neurodegeneration and Stabilizes Tau Against Aggregation. Nat. Chem.Biol. 8:393–
99.  
10. Kreppel LK, Blomberg MA, and Hart GW. 1997. Dynamic Glycosylation of Nuclear 
and Cytosolic Proteins. Cloning and Characterization of a Unique O-GlcNAc 
Transferase with Multiple Tetratricopeptide Repeats. J. Biol. Chem. 272:9308-9315. 
11. Jinek M, Rehwinkel J, Lazarus BD, et al. 2004. The Superhelical TPR-repeat 
Domain of O-linked GlcNAc Transferase Exhibits Structural Similarities to Importin 
Alpha. Nat. Struct. Mol. Biol. 15:1001-1007.  
12. Martinez-Fleites C, Macauley MS, He Y, et al. 2008. Structure of an O-GlcNAc 
Transferase Homolog Provides Insight into Intracellular Glycosylation. Nat. Struct. 
Mol. Biol. 15:764-765. 
13. Lazarus MB, Nam Y, Jiang J, et al. 2011. O-GlcNAc Transferase and its Complex 
with a Peptide Substrate. Nature. 469:564-567.  
14. Leavy TM, Bertozzi CR. 2007. A High-Throughput Assay for O-GlcNAc Transferase 
Detects Primary Sequence Preferences in Peptide Substrates. Bioorg. Med. Chem. 
Lett. 17: 3851-3854. 
15. Ma J and Hart GW. 2014. O-GlcNAc profiling: from proteins to proteomes. Clin. 
Proteomics. 11: 1-16 
16. Zachara NE, O’Donnell N, Cheung WD, et al. 2004. Dynamic O-GlcNAc 
Modification of Nucleocytoplasmic Proteins in Response to Stress. A Survival 
Response of Mammalian Cells. J. Biol. Chem. 279: 30133-30142. 
17. Cheung Wd, Sakabe K, Housley MP, et al. 2008. O-Linked Beta-N-
Acetylglucosaminyltransferase Substrate Specificity is Regulated by Myosin 
Phosphatase Targeting and Other Interacting Proteins. J Biol Chem. 283: 33935-
33941. 
18. Comtesse N, Maldener E, Meese E. 2001. Identification of a Nuclear Variant of 
MGEA5, a Cytoplasmic Hyaluronidase and a Beta-N-acetylglucosaminidase. 
Biochem Biophys Res Commun, 283: 634-640. 
19. Keembiyehetty CN, Krzeslak A, Love DC, et al. 2011. A Lipid-Droplet-Targeted O-
GlcNAcase Isoforms is a Key Regulator of the Proteasome. J Cell Sci. 124: 2851-
2860. 
20. Schimpl M, Schuttelkopf AW, Borodkin VS, et al. 2010. Human OGA Binds 
Substrates in a Conserved Peptide Recognition Groove. Biochem J. 432: 1-7. 
21. Macauley MS, Whitworth GE, Debowski AW, et al. 2005. O-GlcNAcase Uses 
Substrate-Assisted Catalysis: Kinetic Analysis and Development of Highly Selective 
Mechanism-Inspired Inhibitors. J Biol Chem. 280: 25313-25322. 
22. Ruan H, Singh, JP, Li M, Wu J, Yang, X. 2013. Cracking the O-GlcNAc code in 
metabolism. Trends Endocrin. Met. 24: 301-309.  
23. Yki-Jarvinen H, Virkamaki A, DanielsMC, McClain D, Gottschalk WK. 1998. Insulin 
and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal 
muscle proteins in vivo. Metabolism 47:449– 55 
24. Vosseller, K,Wells, L, Lane, MD, Hart, GW. 2002. Elevated nucleocytoplasmic 
glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt 
activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA. 99: 5313–5318 
Sample of an excellent review paper  Appendix III 
62  
25. Macauley, MS, Bubb, A, Martinez-Fleites, C, Davies, GJ et al. 2008. Elevation of 
global O-GlcNAc levels in 3T3- L1 adipocytes by selective inhibition of O-GlcNAcase 
does not induce insulin resistance. J. Biol. Chem. 283:34687–34695 
26. McClain, DA, Lubas,WA, Cooksey, RC, Hazel, M et al. 2002. Altered glycan-
dependent signaling induces insulin resistance and hyperleptinemia. Proc. Natl. 
Acad. Sci. USA. 99:10695–10699 
27. Dentin, R, Hedrick, S, Xie, J, Yates, J, III et al. 2008. Hepatic glucose sensing via 
the CREB coactivator CRTC2. Science. 319:1402–1405 
28. Copeland, RJ, Bullen, JW, Hart, GW. 2008. Cross-talk between GlcNAcylation and 
phosphorylation: roles in insulin resistance and glucose toxicity. Am. J. Physiol. 
Endocrinol. Metab. 295:17–28 
29. Andrali SS, Qian Q, Ozcan S. 2007. Glucose mediates the translocation of NeuroD1 
by O-linked gly- cosylation. J. Biol. Chem. 282:15589–96 
30. Gao Y, Miyazaki J, Hart GW. 2003. The transcription factor PDX-1 is post-
translationally modified by O-linked N-acetylglucosamine and this modification is 
correlated with its DNA binding activity and insulin secretion in min6 β-cells. Arch. 
Biochem. Biophys. 415:155–63 
31. Whelan SA, Dias WB, Thiruneelakantapillai L, Lane MD, Hart GW. 2010. Regulation 
of insulin recep- tor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-
linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. J. Biol. Chem. 285:5204–11 
32. Ruan, HB, Han, X, Li, MD, Singh, JP et al. 2012. O-GlcNAc transferase/host cell 
factor C1 complex regulates gluconeogenesis by modulating PGC-1 alpha stability. 
Cell Metab. 16:226–237 
33. Housley, MP, Rodgers, JT, Udeshi, ND, Kelly, TJ et al. 2008. O-GlcNAc regulates 
FoxO activation in response to glucose. J. Biol. Chem. 283: 16283–16292 
34. Du XL, Edelstein D, Dimmeler S, JuQ, Sui C, Brownlee M. 2001. Hyperglycemia 
inhibits endothelial nitric oxide synthase activity by posttranslational modification at 
the Akt site. J. Clin. Invest. 108:1341–48 
35. Fardini Y, Dehennaut V, Lefebvre T, Issad T. 2013. O-GlcNAcylation: a new cancer 
hallmark? Front. In Endocrin. 4:1-14 
36. Olivier-Van Stichelen S,Drougat L, Dehennaut V, El Yazidi-Belkoura I, Guinez C, Mir 
AM, et al. 2012. Serum-stimulated cell cycle entry promotes ncOGT synthesis 
required for cyclin D expression. Oncogenesis. 36:1-6 
37. Drougat L,Olivier-VanStichelen S, Mortuaire M, Foulquier F, Lacoste AS, Michalski 
JC, et al. 2012. Characterization of O-GlcNAc cycling and proteomic identification of 
differentially O-GlcNAcylated proteins during G1/S transition. Biochim Biophys. Acta 
1820:1839–1848 
38. Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, et al. 
2013. O-GlcNAc transferase integrates metabolic pathways to regulate the stability 
of c-MYC in human prostate cancer. Cancer Res. 73: 5277 
39. Caldwell SA, Jackson SR, Shahri- ari KS, Lynch TP, Sethi G,Walker S, et al. 2010. 
Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis 
through targeting of the oncogenic transcription factor FoxM1. Oncogene. 29:2831–
2842. 
Sample of an excellent review paper  Appendix III 
63  
40. Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS, et al. 2006. Modification of 
p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell 
Biol. 8:1074–83. 
41. Olivier-Van Stichelen S, Guinez C, Mir AM, Perez-Cervera Y, Liu C, Michalski JC, et 
al. 2012. The hexosamine biosynthetic pathway and O-GlcNAcylation drive the 
expression of beta-catenin and cell proliferation. Am J Physiol. Endocrinol. Metab. 
302:417–424. 
42. Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C, et al. 2010. GlcNAcylation plays an 
essential role in breast cancer metastasis. Cancer Res. 70:6344–6351 
43. Jin FZ, Yu C, Zhao DZ, Wu MJ, Yang Z. 2013. A correlation between altered O-
GlcNAcylation, migration and with changes in E- cadherin levels in ovarian cancer 
cells. Exp Cell Res. 319:1482–1490.  
44. Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX. 2004. O-GlcNAcylation 
regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. 
Proc. Natl. Acad. Sci. USA.101:10804–10809. 
45. Yuzwa, SA, Cheung, AH, Okon, M, McIntosh, LP, Vocadlo, DJ. 2014. O-GlcNAc 
modifcation of tau directly inhibits its aggregation without perturbing the 
conformational properties of tau monomers. J. Mol. Biol. 426:1736-1752. 
46. Vocadlo, DJ. 2012. O-GlcNac processing enzymes: catalytic mechanisms, substrate 
specificity, and enzyme regulation. Curr. Opin. Chem. Biol. 16:488-497. 
47. Ma, J, and Hart, GW. 2013. Protein O-GlcNAcylation in diabetes and diabetic 
complications. Expert Rev. Proteomic. 10:365-380. 
48. Sakabe, K, Wang, Z, Hart, GW. 2010. Beta-N-acetylglucosamine (O-GlcNAc) is part 
of the histone code. Proc. Natl. Acad. Sci. USA. 107:19915–19920. 
49. Fujiki, R, Hashiba, W, Sekine, H, Yokoyama, A, Chikanishi, T, Ito, S, Imai, Y, Kim, J, 
He, HH, Igarashi, K, Kanno, J, Ohtake, F, Kitagawa, H, Roeder, RG, Brown, M, and 
Kato, S. 2011. GlcNAcylation of histone H2B facilitates its monoubiquitination 
Nature. 480:557–560. 
50. Mariappa, D, Pathak, S, and van Aalten, DM. 2013. A sweet TET-a-tete-synergy of 
TET proteins and O-GlcNAc transferase in transcription. EMBO J., 32:612–613. 
51. Chen, L, and Daley GQ. 2008. Molecular basis of pluripotency. Hum. Mol. Gen. 
17:23-27. 
52. Jang, H, Kim, TW, Yoon, S, Choi, SY, Kang, TW, Kim, SY, Kwon, YW, Cho, EJ, and 
Youn, HD. 2012. O-GlcNAc regulates pluripotency and reprogramming by directly 
acting on core components of the pluripotency network. Cell Stem Cell. 11:62-74. 
53. Myers, SA, Panning, B, and Burlingame, AL. 2011. Polycomb repressive complex 2 
is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic 
stem cells. Proc. Natl. Acad. Sci. USA. 108:9490-9495. 
54. Kerppola TK. 2009. Polycomb group complexes – Many combinations, many 
functions. Trends Cell Biol. 19:692-704. 
   
 
 
 
Sample of an average paper  Appendix III 
64 
 
Exogenous Advanced Glycation End Products (AGEs), their production and causation 
of disease 
 
Department of Biochemistry, University of Nebraska – Lincoln 
 
Key Words: Exogenous advanced glycation end products, diabetes, cardiovascular 
disease, kidney disease  
 
ABSTRACT  
 Exogenous AGEs are produced both endogenously and exogenously. In this 
review exogenous AGEs will be discussed in relation to their development and then how 
that development causes disease. There are many AGEs that are common in many of 
the staples of the Western diet. This increase causes an accumulation of AGEs in the 
body where they are not sufficiently cleared. This clearance is important because when 
there are too many AGEs in the body the accumulation begins to cause greater 
inflammatory responses, increased oxidative stress in the cell, and greater incidence of 
disease for the future. The development of the disease correlates with the AGE burden. 
Diseases build upon one another and once one disease becomes a problem more will 
follow. As the body begins to have complications the accumulation of AGEs continues 
and the health of the patient continues to disintegrate.  
 
INTRODUCTION 
 
Exogenous advanced glycation end products (AGEs) are found in many of the 
foods that are eaten every day. There are certain diets that include more AGEs and 
there are ways in which to reduce the amount of the AGEs that are produced in the 
food. The way in which the food is processed also contributes to the amount of AGEs 
that are in the food ingested and thus increases the amount of AGEs that accumulate in 
the body.  Once the AGEs are in the body there is some clearance, but not a significant 
amount. The accumulation occurs in concordance with the endogenous AGEs that are 
produced in the body. If the accumulation of AGEs is more than it should be then there 
is a larger chance for disease to occur in the body. Reducing the amount of AGEs in the 
body has important health implications because AGEs add to the incidence and 
worsening of disease. 
 Eating is a necessity or life, but AGE concentration needs to be taken into 
account when processing is occurring. Processing can occur in many different forms 
which may include the cooking process or the pressure that is used when preparing the 
food. In the modern age, more and more food is becoming processed for a variety of 
reasons that can include: longer shelf life, convenience, and cost of the product. 
Processed food makes the product look better on the shelf and extends shelf life, but 
the chemical treatments increase the amount of AGEs that the average person 
consumes (1).  
 Over life AGEs begin to accumulate in the body and age and disease change the 
ability of the person to clear the AGEs out of the body. As the accumulation continues 
there is less chance for clearance and the AGEs will continue to build up in the tissues. 
Sample of an average paper  Appendix III 
65 
 
Chronic kidney disease, diabetes, and cardiovascular disease are all diseases that build 
upon one another and are affected by age and the accumulation of AGEs in the body.  
 
EXOGENOUS PRODUCTION OF AGEs  
 
One of major biochemical reaction resulting in food-born AGEs is the Maillard or 
browning reaction (MR) (2). The MR is a reaction that takes place between a free amino 
group and the aldo or keto group of a reducing sugar (3).  The free amino group could 
come from a variety of places which include amino acids. The MR occurs during 
browning of the food. Browning is a process by which an irreversible change occurs 
within the food which changes the color of the food, usually meat, to a brown color from 
the heat that is applied to the food.  The brown coloring of the food is not the AGEs, but 
a reaction is occurring in conjunction with the browning that will end up producing 
AGEs.  
 The MR occurs in a few small steps which begin with a condensation reaction of 
a free amino group, usually a lysine residue, and the carbonyl group of a reducing sugar 
(9). The Schiff base that is formed then rearranges into a N-substituted glycosamine 
which then transfers into an Amadori product. This Amadori product is an early glycation 
end product. Once this product is formed there is cyclization and dehydration in order to 
form the final AGEs (10). Before the final AGEs are produced there is a possibility of 
reversing the rearrangement that formed the Amadori products (Figure 1)(11). This 
reversal could be used in the future to reduce the accumulation of AGEs that occur in 
the body. Some of the AGEs that are formed through this reaction include Nε-
carboxyethyl lysine (CEL) and Nε-carboxymethyl lysine (CML). Different foods have 
different amounts of AGEs that already exist and data shows that cooking food 
increases the amount of AGEs present in the samples from this reaction (4).  
 
 
Figure 1: The Maillard Reaction (30) 
 
 Once the AGE is ingested it may be metabolized, cleared, or may build up in 
tissues such as vessel walls that affect the extracellular matrix (12).  There are 
endogenous AGEs that are formed physiologically within the body. The endogenous 
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AGEs add to the exogenous AGEs and this combination is a cause of the accumulation 
(5).  There is some evidence that while there is buildup in the body there is also some 
clearance of the AGEs in urine (2).  The clearance is not enough to outweigh the 
amount that ends up in the body and the health concerns result.  
 In high AGE-containing foods there are also health benefits in these foods that 
may be antioxidants because of different compounds that are in the food. On the other 
hand problems in the body due to the AGEs themselves are their ability to promote 
oxidative stress and inflammation (2). For example, bread crust extract (BCE) was used 
to see the quantitative amount of AGEs within the extract and it was found that BCE has 
oxidative properties. On the other hand, decaffeinated coffee extract (CS) has both 
adverse and beneficial effects on the body (2). The CS can cause oxidative stress on 
the body, but also contain compounds that are antioxidants that are good for health (2).  
 Melanonides are a pigment that is formed and found in processes foods. This 
pigment is brown in color and is heterogeneous in structure. Because of this mixture the 
total structure of pigment is not totally understood (6). Depending on the molecular 
weight of the pigment as well as the reactant causes a change in the solubility. Also, in 
protein rich foods there is a cross-linkage that is formed that causes the proteins to be 
cross-linked by carbohydrate-derived structures (1). The melanoidines may be more of 
a positive structure in the body, but at the same time may increase the amounts of 
AGEs that end up being produced.  
 Much of the processing that occurs in the modern food, such as crackers and hot 
dogs, is mainly heat processing and is the primary source of food-derived AGEs (7). A 
reason that there is a contribution to the formation of AGEs would be the fact that foods 
that are high in lipid and protein concentration have free radicals that are produced from 
lipoxidation reactions (4). These reaction products catabolize the formation of AGES 
when meats and fats go through the cooking process (4).Carbohydrates usually have 
the lowest amount AGEs, but the amount changes greatly with increased processing. 
This can be seen in everyday breakfast cereals and is due to the high temperatures that 
are used in making the cereal (4).  
 High temperature and high pressure are usually used together in the processing 
of ready-to-eat snacks and foods. The use of high of pressures can change the product. 
The changes include: dehydration, degradation, and changed in the chemical properties 
of the compound (4). Dehydration is a large problem because this allows for processing 
at high temperatures with low amounts of moisture that increases the amounts of AGEs 
that are produced in the food.  
 The MR is used to form many of the exogenous AGEs. This reaction is used in 
many of the popular foods that are eaten today. AGEs can accumulate in the body 
because there are so many AGEs that are produced outside the body. There is not a 
quantitative value as to how much AGEs are too much, but there is much evidence that 
says that the modern person is eating too many. Figure 2 shows the amounts of AGEs 
that are in many common foods and how the amount is changed with certain cooking 
processes applied to the food.  
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Figure 2: This is a chart of the AGE concentration in many of the common foods (3) 
 
  
METABOLISM OF AGEs 
  
 There are several receptors that are in the body that bind AGEs which contribute 
both to pathogenicity and clearance. After production the AGEs can move through the 
body and there are specific receptors that are used in order for the degradation or 
accumulation of the AGEs to occur (8). These receptors are used for signaling, in 
reactive oxygen species production, and the release of growth factors and cytokines (8). 
This process in low amounts of AGEs helps with turnover and catabolizing the AGEs. 
However, when there are high amounts of AGEs this mechanism accelerates the 
inflammatory response (8).  The receptor that contributes to the pathogenicity and some 
clearance of the AGEs is called RAGE. RAGE is a receptor that is part of the 
immunoglobulin superfamily. This receptor contains four parts of the transmembrane 
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protein which include: two constant domains, one variable domain, a transmembrane 
domain, and a cytoplasmic tail (13,14). Ligand-binding can occur because of the 
variable domain. The cytoplasmic tail is necessary for the signaling cascade that occurs 
when AGEs bind with RAGE (16). Activation occurs when there is an AGE that binds to 
RAGE, but the receptor is not specific to AGEs and can bind other molecules as well. 
When there is such a large variety of molecules that can attach to RAGE there are 
different functions that the receptor can carry out (17). RAGE is involved in the 
inflammatory response and in some ways there is chronic inflammation, but there is 
research that supports a positive function of RAGE with tissue repair (14).  This different 
function shows how RAGE can be different because of what binds to the receptor.  
 RAGE accepts pro-inflammatory ligands which include the following: S100 family 
of proteins, high mobility group protein 1 (HMGB1), β-amyloid peptide (Aβ), and 
macrophage antigen complex 1 (15). RAGE activates two different pathways, 
phosphatidylinositol-3 kinase (PI3-K) and mitogen-activated protein kinases (MAPKs), 
which in turn activates NF-κB (Figure 3) (30). The signaling cascade produces pro-
inflammatory cytokines with the activation of NF-κB. NF-κB also causes the up 
regulation of RAGE which is the source of a positive feedback system which increases 
the amount of inflammatory promoters (31). CML, a common AGE, can also upregulate 
many other pro-inflammatory molecules in the cell (18). RAGE is found on cells that are 
a part of the immune response, especially T cells (13).  
 
 
Figure 3: RAGE mechanism (32) 
 
 A main protein that only has clearance function is AGER1 which is also known as 
OST-48 (21,34). This receptor is found in white adipose tissue, skeletal muscle, and 
liver tissues (35).This receptor was down regulated in disease such as diabetes which 
increases the accumulation of AGEs (21). When there is high amounts of oxidative 
stress, changes with age, or disease this receptor does not work as well and an 
accumulation of AGEs can occur. AGER1 and RAGE are two receptors that work 
against each other and negative regulation of RAGE may increase the clearance activity 
of AGER1. Survival factor sitruin 1 (SIRT1) is a survival factor and a NAD+ -dependent 
deacetylase (21, 35). The function of this protein is to remove acyl groups for many 
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different proteins. SIRT1 works to reduce the effect of AGEs on the body, but it works in 
a different way. AGER1 works as a receptor for the AGEs themselves, but SIRT1 works 
to control NF-κB. As was stated earlier NF-κB upregulates RAGE and helps with the 
activation cascade in order to increase the inflammatory response (35,18)  SIRT1 
decreases the inflammatory response and is tied to the AGER1 function in the cell 
where it has been studied in diabetes (21). This regulation is due to molecules that are 
inducers which are endoplasmic reticulum stress and fatty acids (22).  SIRT1 works to 
regulate adipose tissue inflammation and this is done by regulating pro-inflammatory 
transcription. Through transcription regulation the SIRT1 has many mechanisms by 
which it can affect the inflammatory response. Some of the mechanisms that affect 
SIRT1 are deacetylation and methyltransferase activity. Transcriptional silencing is the 
result of SIRT1 which may reduce the inflammatory response (22). 
 There are also some other receptors for the clearance of AGEs and include: 80K-
H, CD36, and galectin- 3 (33). CD36 belongs to the class B scavenger family. CD36 
causes endocytosis with binding of AGEs and is found in smooth muscle and 
macrophage cells that were found in patients with atherosclerosis (33). Galectin-3 is 
known as AGER3 and is a member of the lectin family and has a variety of functions. 
These functions include: cell to cell interactions within the cell matrix where it works to 
decrease adhesion, mast cell activation, some gene expression control due to splicing 
of pre-mRNA, and the degradation of AGEs because of the high affinity that this 
receptor has for them (34). 80K-H or AGER2 also has a function that independently is 
unknown but with these other receptors there is thought that they work as a complex 
and are implicated in the clearance of AGEs rather than increasing the inflammation 
response that RAGE is known for (34).  
 There is both clearance and accumulation of AGEs in the body. Receptors 
contribute to most of the inflammatory response and the clearance of AGEs from the 
body. AGEs have seen to increase the amount of RAGE that is seen in the cell while 
there seems to be an upregulation of AGER1 when there is a lower amount of AGEs in 
the cell (42). This change in the receptors on the cell also affects the lifespan of the 
mouse that it was tested on. When there was a diet that was lower in AGEs there was 
an increased lifespan for the mouse than of those mice that had a diet in higher AGEs 
(42).  The accumulation of the AGEs contributes to the incidence of disease because 
the RAGE receptor causes there to be a signaling pathway that allows for the disease to 
continue it pathogenicity in the body. The incidence of disease also increases with age, 
and the clearance of AGEs reduces with age which thus increases accumulation.   
 
DISEASE COMPLICATIONS   
 
 There are some similarities that are evident in all of the diseases and there are 
complications from the diseases that build upon one another. Oxidative stress is 
important in the incidence of chronic kidney disease, diabetes, and cardiovascular 
disease. The oxidative stress affects the normal functioning of the cell and inhibits the 
normal protein function (40). AGEs are part of the pro-inflammatory response and in 
that response the oxidative stress is increased as well. Once the inflammation response 
is generated this causes a cascade to occur and cause more problems in the cell. This 
is one way in which the diseases build upon one another. The problems begin small, but 
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over time the health concerns compile and larger and more severe health issues 
become apparent. In this case there is an incidence of disease that is highly related. For 
example, kidney disease and diabetes are also risk factors for cardiovascular disease. 
The risk factors, if not treated, will cause there to be more disease and illness in the 
future for the patient. Also, age has an impact on the disease of a person. As the person 
ages the body does not work as well and the incidence of disease also reduces the 
ability of the body to fight off infection and decrease the health of the patient (23).  
 
Chronic Kidney Disease  
 
 Chronic kidney disease is separated into indistinguishable stages that will end up 
causing total nephron dysfunction on the kidney (27). Diabetes will cause much of the 
renal failure in the United States and the renal failure can also increase the chance of 
having micro-vascular disease that can lead to stroke and heart attack (26).  As chronic 
kidney disease continues there is more of an accumulation of AGEs which will continue 
to make the incidence of disease increase (26).  When there is any amount of AGE 
clearance from the body it is done by the kidneys.  There is some reabsorption in the 
proximal convoluted tubule of the nephron, but there is also some that is degraded and 
excreted in the urine (37). The reabsorption and degradation occurs after filtration. If 
filtration is compromised then there will be less excretion and the AGE will accumulate 
in the renal tissue (37). As the functionality of the kidneys decreases the amount of AGE 
accumulation continues. There is a positive correlation with AGE accumulation and 
oxidative stress as well as a negative correlation with AGE accumulation and glomerular 
filtration. Diabetes and chronic kidney disease together will increase the incidence of 
cardiovascular disease more than those with just chronic kidney disease (24).  
 Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase 
inhibitor which has seen an increase in both this disease and diabetes (26). AGEs 
inhibit the enzyme that breaks down this product. ADMA increases vascular injury and 
increases oxidative stress. ADMA that is increased in chronic kidney disease can affect 
other aspects of health as well including high blood pressure (27). ADMA is usually 
excreted from the body via the kidneys. When there is decreased or lost function of the 
kidneys then there is higher amounts of ADMA in the blood which impairs the function of 
nitric oxide synthase (NOS) (27).Nitric oxide is important in a variety of physiological 
functions and without the synthesis of the molecule there will be continued development 
of the complications. With the reduction of nitric oxide there is an increase in insulin 
resistance (36). This is just another example where there are diseases that all work 
together to cause the patient more and more complications.  
 
Type II Diabetes  
 
 Diabetes is increasing its rate of development in this country for a variety of 
factors which include changes in diet, the increased sugar in foods, and also the 
amount of AGEs that are accumulated in the body. RAGE is still an important receptor 
when it comes to the pathogenesis in diabetic neuropathy (25). Diabetic neuropathy is 
nerve damage that occurs with the continuation of the disease. RAGE is higher in 
nerves of a person who is hypoglycemic than those who are nondiabetic. RAGE and 
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AGEs have been implicated in developing and continuing the disease (25). The exact 
mechanism by which this occurs is still unknown. However, it is thought that AGEs work 
to decrease the work of Schwann cells in the nervous system. Schwann cells work to 
myelinate nerve cells which increase the rate of the impulse moving along the axon. 
Both of the previous factors increase other types of disease as well (40). With a 
decrease in the speed of the impulse which causes there to be a degeneration of the 
nerve cells which can eventually cause cell death (40).  
 ADMA is also present in higher levels in diabetes which can also lead to the 
incidence of cardiovascular disease because nitric oxide is used to keep the shape of 
vessels in the body (28). As was stated earlier a decrease in nitric oxide decreases the 
sensitivity to insulin which would cause the diabetes to get worse over time with the 
increased accumulation of AGEs.  
 The increased amount of sugar that is in the blood in diabetic patients increases 
the amount of glycation that occurs. The AGEs accumulate in many tissues where there 
is diabetic complication such as kidney and retina and it accumulates intracellulary (38). 
This accumulation can interfere with the proteins within the cell and modify signaling 
pathways. The signaling pathways of RAGE and AGER1 were discussed above and the 
binding of the AGEs to different receptors causes a different response in the cell.  
 Diabetic retinopathy is a cause of blindness in diabetic patients and is caused by 
the increased spreading of blood vessels in the eye and thickening of the basement 
membrane within the eye. AGEs are important in this aspect of diabetes because they 
are found to play a role in the dysfunction of retinal cells that may end up leading to the 
death of the cells (38). Cataracts are another cause of blindness in diabetic patients and 
occur when the lens becomes opaque and slowly causes the loss of vision. It has been 
stated that AGEs cause a change in the proteins of the cell that they are in. In the 
problem of diabetic cataracts, AGEs cause a change in the charge of the proteins. This 
change causes a disruption in the cooperation between the protein-protein and protein-
water interactions that will lead to blindness (39).  
 
Cardiovascular Disease   
  
 Cardiovascular disease arises from these other complications in a variety of 
ways and arterial stiffness is a large problem with the accumulation of AGEs. 
Cardiovascular disease is a wide array of problems which include blood vessel 
thickness, risk for clotting, and maybe heat attack or stroke (41). Accumulation of AGEs 
causes an increased cross-linking with collagen in the vessels which in turn causes 
there to be more arterial stiffness (25).  This cross-linking also causes there to be 
problems with high blood pressure because there is less action of the enzymes to break 
down the collagen that is forming in the vessels (41).  
 The nitric oxide concentrations in the blood are also a large factor in 
cardiovascular health. The nitric oxide is a vasodilator and ADMA inhibits the production 
of the nitric oxide which causes the vessels to have a higher risk for heart attack or 
stroke. Cardiovascular disease becomes a problem when there are many other ailments 
with a patient. As it has been seen when there is chronic kidney disease or diabetes the 
incidence of cardiovascular disease is higher.  
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Conclusion  
 
 AGEs are a part of the body and can be ingested exogenously. The excess 
amount of the AGEs is what causes the problems in disease and clearance. Without 
sufficient clearance of the AGEs there is down regulation of receptors that help with 
clearance (AGER1) and increase in receptors that increase the inflammatory response 
(RAGE). With an increase in the RAGE receptor there is an increase in the oxidative 
stress that is put on the cell. With this increase there is more disease that develops. And 
the diseases build upon each other.   
The Maillard reaction is the main reaction with food that causes there to be a 
production of AGEs.  This reaction is found in some cooking methods and can also be 
found in some processing methods. Many foods, especially proteins, already have an 
AGE content, but frying or broiling meat can increase the amount of AGEs that are 
found in the body (2). There is not an amount of AGEs that have been proven to cause 
the adverse side effects.  It is known that too much is a problem, but there is not a 
quantifiable amount that this refers too.  
 Once the AGEs are in the body there are many things that can happen to them. 
This has to do with the type of receptor that the AGE binds to once in the cell. There is 
RAGE which causes there to be inflammation and a signaling cascade which will 
activate the cell cause more problems downstream (15). On the other hand there are 
receptors such as AGER1 which work to degrade and excrete the AGEs from the body 
so that they cannot cause any harm while they are there. The incidence of these 
receptors is also regulated by the amount of AGEs that are already accumulated in the 
cell. Even with the use of AGER1 there are not enough of the AGEs that are excreted 
from the body and the accumulation of them causes there to be disease in the cell (21).  
 The diseases that are caused in the body due to the AGEs are vast and three of 
the common ones are chronic kidney disease, type II diabetes, and cardiovascular 
disease. These diseases build upon one another to cause even more problems in the 
cell and over time will just continue to get worse and worse. As age increases the 
amount of AGEs in the cell also increase as well as the incidence of disease.  
 The main way to alleviate this problem is to reduce the amount of ingested AGEs 
in the diet. This could be done by reducing the amount of meat that is ingested because 
there is going to be a lot of AGEs that are ingested with the cooking process of meat. 
Protein is necessary for survival, but the protein that is eaten could affect the amount of 
AGEs ingested (1). Also, portion size is a factor and should be reduced in the diet. If the 
patient wanted to decrease the amount of AGEs they could reduce overall portions and 
eat a healthier diet. There is not conclusive evidence that exercise reduces AGEs, but 
there is evidence that a healthy and balanced diet along with exercise will create a 
healthier person and the impact of AGEs will be reduced.    
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Advanced Glycation End Products (AGEs) Play a 
Complicated Role in Human Health and Pathology 
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INTRODUCTION 
 
Advanced glycation end products (AGEs) are produced when reducing sugars non-
enzymatically modify proteins. These reactions are collectively called Maillard reactions. The 
addition of a carboxyl group to proteins affects the physical properties of proteins, as well as 
changing their biochemical function. These are posttranslational modifications that accumulate 
in long-lived proteins with age. AGEs affect health in a variety of ways. There are four main 
ways that AGEs cause harm to the body. First, they change protein function through 
modification. The original protein is no longer able to execute its intended function, and instead 
will be recognized by the receptor for advanced glycation end products (RAGE). When AGEs 
are recognized by RAGE, an inflammatory response is induced. AGEs are also involved in the 
crosslinking of proteins, which stiffen tissues. Finally, AGEs induce radical formation, which 
accelerates body aging. 
 
RAGE is the main receptor that binds AGEs. It is an interesting receptor, due to its ability to bind 
a wide variety of ligands while differentiating between them. The binding of AGEs to RAGE 
leads to the production of pro-inflammatory cytokines, along with reactive oxygen species. This 
inflammation plays a role in diseases such as diabetes. 
 
AGEs are important in a multitude of diseases. AGEs may play a role in the development and 
progression of Alzheimer’s disease. AGEs have been implicated in several diabetic 
complications, mostly due to an increase of AGEs caused by higher blood sugar levels. Another 
issue arising from AGEs in diseases is the accumulation of AGEs in chronic injury and disease. 
  
How and Why AGEs are Produced in the Body  
 
Advanced glycation end products, or AGEs, are posttranslational modifications of proteins (5). 
They are produced endogenously through random Maillard reactions, whenever sugars and 
proteins are in contact. The Maillard reactions consist first of the formation of a Schiff base(18), 
which links the amino group (usually from a Lysine or Arginine) of the protein to the carbonyl 
group of the sugar (28). It then undergoes an Amadori rearrangement, forming a ketosamine. 
These first two reactions occur in a matter of hours, and are reversible. The ketosamine then 
undergoes dehydration, and various other rearrangements, which depend on the specific 
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protein. This reaction is irreversible, and occurs over a matter of days (29). These reactions are 
random, and are more likely to occur when sugar is present in the body at higher 
concentrations, due to more opportunities for sugar to come into contact with proteins (6). 
Therefore some biological conditions, such as oxidative stress and increased blood sugar 
concentrations, can increase the probability of AGE formation. The formation of AGEs alters the 
protein’s normal function. In some cases, this also reduces the protein’s susceptibility to 
degradation, allowing AGEs to build up in specific tissues. This is mostly an issue in tissues 
such as collagen, where AGE build up stiffens the tissue, eliminating its key elasticity functions. 
 
Proteins that are longer-lived are more prone to AGE formation, as their long life-span allows for 
a longer contact time and greater chance for them to react with sugars (14). However, shorter-
lived proteins are also likely to form and accumulate AGEs when oxygen is present. This is 
shown by AGE formation in metabolic proteins occurring under oxidative stress. Since AGEs 
reduce a protein’s susceptibility to degradation, this allows for a buildup of altered proteins that 
would not normally occur. These modified proteins target several key enzymes in energy 
production, such as creatine kinase and carbonic anhydrase III, preventing them from 
functioning properly (12). 
Glucose is the most common sugar found in human blood, and it is able to produce AGEs. One 
would likely assume then, that glucose plays a major role in the glycation of proteins. However, 
the Maillard reaction of glucose in vivo is slow at physiological temperature and pH due to its 
low reactivity. Glucose’s low reactivity prevents it from glycating the majority of short-lived 
proteins. Long-lived proteins, such as collagen and elastin, are much more likely to be affected 
by glycation from glucose, due to their prolonged interaction times. Therefore, glucose only 
accounts for a small portion of AGE formation. 
The two most thoroughly researched AGEs are carboxymethyllysine, CML (Image 1), and 
carboxyethyllysine, CEL (Image 2). They are closely related, and differ by a single methyl group. 
They are formed through the modification of lysine residues, and change the positively charged 
side-chain to a negatively charged side-chain. CML and CEL are oxygen-dependent AGEs, and 
have been shown to induce several harmful biological responses, such as the NF-kB pathway, 
which is involved in immune response (26). Some flavonoids have a paradoxical effect on redox 
status. Flavonoids such as genistein inhibit AGE production by binding with and trapping their 
precursors (17). This may be explained by catechol-rich flavonoids increasing oxidative stress, 
which leads to an increase in CML production (16). 
 
Ribose is a monosaccharide whose effects on AGE formation have not been studied as in-depth 
as some more common sugars. However, this pentose sugar has a high glycation reactivity 
when compared to hexose sugars such as glucose. It has been found to react with collagen to 
form CML in vivo, and mechanistically may react with many of the same proteins that the 
hexose sugars and hexose phosphates react with to form AGEs. On the other hand ribose and 
R5P can create a new glycation product, norpronyl lysine; that has not been found to be formed 
through hexose reactions. The formation of norpronyl lysine brings ribose forward as a new area 
to study for AGE formation (7). 
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Endogenous AGE formation occurs under a variety of biological conditions. Since these 
reactions are not specific, and generally promote immune responses, it is likely that they are 
inadvertent side effects caused by sugar being in contact with proteins. Sugars are necessary to 
biological functions, as they are a major source of energy in humans. However, an abundance 
of sugar present in the body in a reactive state will cause unfortunate side effects. 
 
The elimination of endogenously produced AGEs from the body is slow (1), as most of them will 
accumulate in tissues, rather than be released into the blood where they could be filtered out. 
Exogenously produced AGEs are much more likely to be present in the blood rather than in 
tissues, so they are more likely to be eliminated from the body. When AGEs are present in the 
blood, they will temporarily accumulate in the liver, then move to the kidney where they are 
excreted in urine (3). Impaired kidney function can lead to a significant increase of AGEs 
present in the body, due to a failure in renal elimination of exogenously produced AGEs.  These 
AGEs could then go onto accumulate in other tissues, since higher concentrations in the blood 
would give them longer contact times with other tissues. 
  
How AGEs Harm Human Health 
 
Advanced glycation end products are harmful to human health. AGEs are present and 
destructive in healthy individuals, as well as those with diseases. It is difficult to fully understand 
AGEs’ impact on health as they can affect any protein in the body. There are four main ways 
that AGEs impact health. AGEs 1) change protein function through modification, 2) they cause 
crosslinking between proteins which stiffens tissue, 3) they induce an inflammatory response by 
binding to the receptor for advanced glycation end products (RAGE), 4) and they induce radical 
formation. AGEs may impact health in other ways, but these are the most common effects. 
  
First, AGEs change protein function through modification. By changing the positive amine group 
on Lysine or Arginine residues to a negative carbonyl, it can change both the physical and 
chemical properties of the protein. The effects of the AGE will depend on the specific protein 
being modified. Some proteins will not be greatly affected, whereas others will change 
drastically due to the added carbonyl. If the location of the modification is involved in folding, or 
in binding, it can affect the protein to the point where it can no longer perform even a portion of 
its intended function. 
 
Second, AGEs can cause crosslinking between proteins. This crosslinking stiffens the tissue, 
which can cause a myriad of health implications. Collagen is one of the tissues most affected by 
crosslinking, since it is long lived and will accumulated AGEs (14). Healthy collagen is 
somewhat flexible, but as collagen accumulates AGEs it loses its flexibility and stiffens. This 
prevents collagen from properly performing its normal functions (39). 
 
Third, the receptor for advanced glycation end products (RAGE) is a complicated receptor. It 
has to be able to bind to a wide variety of ligands (15), due to the diversity of AGEs.  One of 
RAGE’s major implications in health is its involvement in inflammation. When AGEs bind RAGE, 
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it leads to activation of transcription factor NFKB, which promotes further AGE formation. This 
induces a positive feedback loop where AGEs bind to RAGE, which leads to more AGE 
production, which leads to more AGEs binding RAGE, and etc. 
  
Fourth, AGEs can induce radical formation. The formation of AGEs, particularly the Schiff 
bases, creates active sites for catalyzing free radical formation (31). Free radicals are harmful to 
health due to their high reactivity (23). 
  
Receptor for Advanced Glycation End Products 
 
The receptor for advanced glycation end products (RAGE), is a transmembrane protein. RAGE 
is an immunoglobulin cell surface receptor (19), and is a pattern recognition receptor (PRR), 
which allows it to bind to the wide variety of AGEs. RAGE can undergo splicing to form a variety 
of forms. The four most common are full-length RAGE (FL-RAGE), N-terminal truncated RAGE 
(Nt-RAGE), endogenous secretary RAGE (ES-RAGE), and soluble RAGE (sRAGE) (47). The 
sRAGE variant may be formed due to protease activity as well as splicing. sRAGE is just the 
extracellular ligand binding domain of RAGE, which allows it to act as a decoy, binding the 
ligand before it can bind with FL-RAGE. This makes sRAGE a good candidate for future 
therapeutic studies. 
 
RAGE has been identified in monocytes, macrophages, microglia, astrocytes, neurons, smooth 
muscle, endothelial cells, lymphocytes, and leukocytes (11). It is found on a variety of cells, and 
can bind a variety of ligands. Unfortunately, this makes RAGE difficult to study as a whole, and 
most studies focus on one specific activity of RAGE, rather than the receptor’s overall activity. 
However, kinases such as mitogen activated protein kinases (MAPKs) have been implicated as 
components of the RAGE signaling pathways. MAPKs are known to be induced by cytokines 
and stressors (25). These kinases are an area that needs to be studied more in the future, as 
they could be the key to a more thorough understanding of RAGE.  
 
The cascade of signal transduction depends on RAGE binding with AGEs. Blocking RAGE with 
either sRAGE or an anti-RAGE antibody will prevent cellular activation. The ligand-RAGE 
interaction activates NFkB (nuclear factor-kappaB), a transcription factor, through the MAPKs 
signaling pathway (4, 36, 42). This pathway is involved in many diseases, including cancers and 
multiple sclerosis (MS). Animal models have shown suppression of tumor growth and 
autoimmune responses in these diseases when sRAGE has been administered (47). 
 
The expression, activation, and release of RAGE contribute to disease-associated inflammation. 
This is inflammation is increased through a self-perpetuating pathway. 
  
AGEs and Disease 
 
Advanced glycation end products play a complicated role in diseases. There is not much 
research pointing to AGEs being the cause of diseases. However, many diseases cause 
biological conditions, such as high blood sugar levels, that make AGEs more likely to form. 
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Since there are then more AGEs being produced in the diseased state, the AGEs are more 
likely to affect overall health. 
  
There has been recent evidence showing that AGEs may play a role in Alzheimer’s Disease 
(AD) (31, 47). It is difficult to say how involved AGEs may or may not be in the development and 
progression of AD, since the disease itself is not well understood. The brain has a high amount 
of oxidative stress, which may lead to more AGE formation. Also, glucose is the primary energy 
source for the brain, so it is present in higher concentrations than other areas of the body. 
Glucose is a reducing sugar that may form AGEs, so the higher concentrations may also lead to 
more AGE formation. With conditions in the brain being favorable for AGE formation, the recent 
studies linking AGEs and Alzheimer’s Disease are promising, but need to be studied further. 
 
One known factor is that accumulation of amyloid-beta peptide and tau protein are important to 
Alzheimer’s Disease (8, 32). AGE induced crosslinking may lead to this aggregation. It is also 
hypothesized that the amyloid precursor protein expression may be upregulated by AGEs. Also, 
the ApoE4 protein (an isoform of ApoE) is associated with Alzheimer’s Disease. This isoform 
has shown a higher binding activity to AGEs than other isoforms, which could provide a link 
between AGEs and AD (31). So far, the research linking AGEs and Alzheimer’s Disease looks 
promising, but it is by no means definitive. 
  
Diabetes is a thoroughly researched disease, and certainly the most researched in regards to 
AGEs (22). The focus on this research seems to focus on the increased production of AGEs 
due to higher blood sugar levels, along with AGEs overall health effects. AGEs have been 
linked to peripheral neuropathy (2), a form of nerve damage often seen in diabetics. AGEs have 
also been implicated in diabetic retinopathy (10), likely due to inflammation caused by AGEs 
binding to RAGE (35). 
 
It has previously been mentioned that sRAGE shows promise as a competitive binder of AGEs. 
It is important to note that sRAGE can also have a detrimental effect on the health of those with 
diabetes (3, 47). A higher concentration of sRAGE in the blood has been linked to an increase 
in inflammatory markers such as tumor necrosis factor (TNF)-α and monocyte chemo attractant 
protein-1 (MCP-1). Before sRAGE therapeutics can be looked upon as he future of the field, the 
complex interactions between AGEs, RAGE, and sRAGE needs to be better understood. 
  
Conclusion and Future Perspectives 
 
AGEs are produced both endogenously and exogenously; through random, non-enzymatic 
chemical reactions. These Maillard reactions are unavoidable. AGEs are harmful to human 
health for a variety of reasons. The most prevalent of these is the alteration of the protein 
preventing it from performing its intended duties. AGEs will also cause crosslinking between 
tissues, which stiffen the tissues and impair their normal activities. The binding of AGEs to 
RAGE causes a signaling cascade that proves to have many detrimental effects. Some of these 
include promoting tumor growth in cancer, and promoting autoimmune responses especially in 
diseases such as MS.  
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The most promising areas for future studies of AGEs focus on either diseases or RAGE.  
 AGEs have proven to be linked to Alzheimer’s disease and diabetes. However, these links are 
not well understood. A more thorough understanding of these links could lead to a better quality 
of life for people suffering from these conditions. Alternatively, studying RAGE isoforms such as 
sRAGE could lead to preventative therapeutics. 
 
 
  
 
Image 1 CML 
 
 
 
Image 2 CEL 
 
 
 
 
Image 3 Lysine 
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Abstract #1 Sample of well-written abstract
BIOC 435 
2/12/14 
Recent studies have suggested a strong correlation between Alzheimer’s disease (AD), 
a neurodegenerative disorder, and vascular abnormalities, therefore this study intended to 
establish direct damage of neurons from AD patients’ cerebral vasculature in vitro.  Using 
isolated blood vessels from human autopsy brain specimens, this study determined AD 
microvessels with neurons caused a significantly greater amount of neuronal cell death in 
conditioned media and direct co-culture.  Neuronal cell death through apoptosis, determined 
from enzyme-linked immunosorbent assays, was found to be more prominent at lower toxic 
concentrations of the AD microvessel conditioned media.  Neuronal cell death also occurred 
through necrosis, measured by cytoplasmic lactate dehydrogenase (LDH) levels, which was 
discovered to be more common at higher concentrations of the toxic AD conditioned media.  It 
was concluded that the AD vascular cytotoxicity is neurospecific because it was shown to only 
affect differentiated neuronal cells and did not kill undifferentiated (non-neuronal) cells.  This 
study deduced that the toxic factor’s identity was not nitric oxide, tumor necrosis factor-α (TNF-
α), nor amyloid β.  Due to its sensitivity to trypsin and heat, along with its inhibition by 
cycloheximide, the toxic factor(s) was determined to most likely be a protein.  This is the first 
study to establish neurotoxic factors from cerebral vascular system in AD.  The results of this 
study support the endothelium-mediated neurodegeneration (END) hypothesis that AD neuronal 
injury results from soluble factors produced by brain microvessels, while shedding light on a 
new potential therapeutic for AD.   
240 
BIOC 435 Sample of an average abstract
02.12.2014 
Alzheimer’s disease (AD) is characterized in part by neuronal cell loss that is poorly 
understood but recent findings in the role of vascular tissue in the pathogenesis of AD 
dementia along with the identification of anatomical and physiological abnormalities in 
AD patients suggest that the tissue is dysfunctional and may have a direct effect on 
neural cellular loss. The aim of this study is to determine whether vascular tissues from 
AD patients can directly injure neurons in culture.  Human microvessels were isolated 
from cortices of AD brain specimens and control samples from patients without 
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evidence of neuropathology which were incubated to form microvessel-conditioned 
media. Neuronal cultures derived from rat cerebella were exposed to different levels of 
conditioned media or co-cultured over variable time periods and the rate of cell death by 
necrosis and apoptosis was measured. Results showed that nearly identical cell death 
rates were observed for microvessel-conditioned media exposure and co-cultures with 
virtually no cell death in non-AD media, which suggest that the lethality of AD 
microvessels is not dependent on a feedback loop. Subsequently, exposure to 
cyclohexamide inhibited the neurotoxic factor decreasing cell death and suggests it is 
likely a protein. The pre-incubation of the microvessels with a number of compounds, 
while not revealing the identity of the neurotoxic factor(s), removed likely candidates. 
AD microvessel cytotoxicity is neurospecific as low rates of cell death was observed in 
non-neuronal cultures. Neuronal cell death was observed by both apoptosis and 
necrosis and was both microvessel dose- and time dependent. While the exact 
neurotoxic factor(s) is not identified it is clear that it neurospecific and understanding its 
mechanisms and role in pathogenesis is crucial to develop effective therapies. While the 
exact effect may be different in-vivo the results of this study provide groundwork for 
expanded study of the pathogenesis of AD. 
300 
Sample of a poorly written abstract 
Alzheimer disease may be defined in few characteristic dementia, amylpoid –B- 
despostion, plaques, tangles, neuronal cell. Recent Studies of scientist shown that the 
roll of blood vessel in the pathogenesis was significant cause of cerebvascular disease. 
The abnormalities was discovered specially in receptor and intravascular signal cause 
of in protein kinase C and AMP. Nitric oxide was potential neurotoxin could cause 
death. Main outcome came from the human brain the procedure occur in micro vessel 
was isolated cautiously in essen was observed by phase constant microscopy. 
Microvessel was put back in (DMEM) Dulbucco modified eagles medium it contained 
fetal calf serum and dimethylsulfoxide and kept in liquid nitrogen. Microvessels were 
then   incubated in CO2 incubator, centrifuged conditioned medium sterile filtered.   The 
neuronal cell death was caused by direct co culture of micorvasssels the condition 
media from brain microvassels were higher cause of cell death. Average with 
conditioned medium the age were varied 32-59 year of age NON-AD. The Result lethal 
effect in AD micovessels is not dependent on neurons and microvessels the medium 
can also be neurotoxic. The outcome shown that Nitric oxide was not responsible for the 
microvessel media it was synthase L1-tosylamide-2-phenylethyl chromomethyl ketone.  
Our understanding the pathogenesis of Alzheimer’s disease to emphasized that the  
neuronal cell death mediated by isolating blood vessel.  
215 
Class format 
1. I give 12 lectures.
2. Students present a paper between each lecture on topic that I discussed in prev. day.
3. Students work on review paper and writing assignments throughout semester.
4. After spring break, all class time is used for student presentations (2/day).
ACE 10 course 
Appendix V
Why use JITT??? 
• Most topics in the course have not been covered in previous courses
• Most topics are very relevant for the world around them
• Importance of biochemistry in daily life
Appendix V
High fructose corn syrup is in many products that we eat and 
drink.  Choose one of the following and justify your answer. 
1. It is good for us because of a balanced nutrition and it is made from
a natural product. 
2. It is neither good for us nor bad for us.
3. It is bad for us.
JITT #1 (1/17/14) 
Appendix V
Question:  What is caramelization (think cooking) and explain some of 
the chemistry that is going on? 
Cross-linking or similar reaction of proteins 
No clue Modifications of starches 
JITT #2 1/24/14 
Appendix V
How does Mucinex work? 
JITT #3 2/9/14 
Appendix V
Imagine that you have discovered a protein and determined the sequence.  The 
amino acid sequences reveals that 8 sites may be modified by subtrate #1 (ex. 
phosphorylation).  Those same 8 sites may also be modified by substrate #2. 
How many different species of this protein would be possible if only substrate #1 
was allowed to act on the protein? 
How many different species of this protein would be possible if both substrates 1 
and 2 are allowed to act on the protein? 
JITT #4 (2/20/14) Appendix V
Outcomes 
• Over 75% of the students thought the JITT helped them better prepare for the
lecture.
• 1/24 asked it to stop and thought it was just busy work.
• Very weak to no relevance for exam scores (n=1).
• Students want answers explained so plan to spend time on that.
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